Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Hong Kong Exchanges and Clearing Limited    0388   HK0388045442

HONG KONG EXCHANGES AND CLEARING LIMITED

(0388)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Hong Kong Exchanges and Clearing : ORANGE APPLICATION FORM

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/11/2019 | 07:02pm EDT

AssuredEntitlement配額

保證

ORANGE FORM 橙表(Assured Entitlement 保證配額)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Please staple your payment here

請將股款

緊釘在此

This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company") dated 12 September 2019the "Prospectus".

本申請表格使用上海復宏漢霖生物技術股份有限公司(「本公司」)於二零一九年九月十二日刊發的招股章程(「招 股章程」)所界定的相同詞彙。

Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act.

本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根 據美國證券法登記或豁免登記,香港發售股份不得在美國提呈發售或出售。

This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any

manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of

that jurisdiction.

任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得發送或派發或轉載(不論 方式,亦不論全部或部分)本申請表格及招股章程。

Copies of the Prospectus, all related Application Forms and the other documents specified in the "Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection - Documents Delivered to the Registrar of Companies" section in Appendix VII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), Hong Kong Securities Clearing Company Limited ("HKSCC"), the Securities and Futures Commission of Hong Kong (the "SFC") and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents.

招股章程、所有相關申請表格及招股章程附錄七「送呈香港公司註冊處處長及備查文件-送呈公司註冊處處長文 件」一節所述的其他文件均已根據香港法例第32 章《公司(清盤及雜項條文)條例》第342C 條規定送呈香港公司註 冊處處長辦理登記。香港交易及結算所有限公司、香港聯合交易所有限公司(「聯交所」)、香港中央結算有限公司 (「香港結算」)、香港證券及期貨事務監察委員會(「證監會」)及香港公司註冊處處長對此等文件的內容概不負責。

ApplicationSampleForm.警告:任何人士僅可為本身利益以橙色申請表格

Shanghai H nlius Biot ch, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

(A joint stock company incorporated in the P op 's R public of China with limited liability)

(於中華人民共和國註冊成立的股份有限公司)

Stock code

:

2696

股份代號 :

2696

Maximum Offer Price

:

HK$57.80 per Offer Share, plus brokerage fee of

1%, SFC transaction levy of 0.0027% and Stock

Exchange trading fee of 0.005% (payable in full

on application in Hong Kong dollars, subject to

refund)

最高發售價 : 每股發售股份57.80港元,另加1%經紀佣金、

0.0027%證監會交易徵費及0.005% 聯交所交易

費(須於申請時以港元繳足,多繳款項可予退

還)

Applic nts' decl r tion

申請人聲明

I/We agree to the terms nd conditions and application

本人吾等同意本申請表格及招股章程的條款及

procedures in this Application Form and the

條件以及申請程序。請參閱本申請表格「丁. 填交

Prospectus. Please refer to the "D. Effect of completing

本申請表格的效用」一節。

and submitting this Application Form" section of this

Warning: Only one application may be made for

the benefit of any person for Reserved Shares on 就預留股份作出一次申請。下列情況將不獲受 an ORANGE Application Form. The following are 理:就預留股份作出的重複或疑屬重複申請以及 liable to be rejected: multiple or suspected multiple 支票或銀行本票在首次過戶時未能兌現的申請。

applications for Reserved Shares and applications where cheques or banker's cashier orders are dishonoured upon the first presentation.

AssuredEntitlement配額

保證

ORANGE FORM 橙表(Assured Entitlement 保證配額)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Name(s) and address of the Qualifying Fosun International Shareholder

User ID 使用者編號

合資格復星國際股東姓名╱名稱及地址

Access Code 通行編號

CCS6536

Apply for Assured Entitlement of Reserved Shares

Box A

Number of Fosun International Shares registered in your

You may apply for a number of Reserved Shares pursuant to your Assured Entitlement that is equal to or less than the number stated

甲欄

name as at 4:30 p.m. on Wednesday, 4 September 2019

in Box B. If you intend to apply for a number of Reserved Shares that is less than your Assured Entitlement, you MUST apply for a

(the "Record Date"):

number which is one of the numbers set out in the table below (other than HKSCC Nominees). If you intend to apply for a number of

於二零一九年九月四日(星期三)(「記錄日期」)下午四時

Assured Entitlement which is not one of the numbers set out in the table below, you MUST apply by using ORANGE Form eIPO

三十分以 閣下名義登記之復星國際股份數目:

only. If you wish to apply for excess Reserved Shares in addition to your Assured Entitlement, you should complete and sign the

Orange Application Form for excess Reserved Shares and lodge it, together with a separate remittance for the full amount payable on

Box B

Number of Reserved Shares in your Assured Entitlement:

Amount payable if your Assured Entitlement is taken up

application in respect of the excess Reserved Shares applied for or apply through the Orange Form eIPO service via www.eipo.com.

乙欄

閣下所獲保證配額之預留股份數目:

in full:

hk.

閣下保證配額獲全數接納應付款項:

You need to complete and sign this Application Form and submit one cheque (or banker's cashier order) for the exact amount of

HK$ 港元

remittance printed in Box B on the right or in the table below.

申請保證配額之預留股份

閣下申請保證配額之預留股份數目可相等於或少於乙欄列明的數目。倘 閣下擬申請的預留股份數目少於 閣下的保

證配額, 閣下必須申請下表中載列的其中一個數目(香港結算代理人除外)。倘 閣下擬申請不在下表中載列的其中

一個保證配額數目, 閣下必須用橙表eIPO 申請。倘 閣下擬申請保證配額以外的超額預留股份,則須填妥並簽署申

請超額預留股份之橙色申請表格,並單獨匯款足額支付所申請超額預留股份的應付股款,或透過www.eipo.com.hk使

橙表eIPO 服務遞交申請。

閣下須填妥及簽署本申請表格並提交一張支票(或銀行本票)支付於右方乙欄或下表列明的應付確切金額

NUMBER OF RESERVED SHARES THAT MAY BE APPLIED FOR AND PAYMENTS

可供申請認購的預留股份數目及款項

Amount payable

Amount payable

Amount payable

Amount payable

No. of Reserved

on application

No. of Reserved

on application

No. of Reserved

on application

No. of Reserved

on application

Shares applied for

HK$

Shares applied for

HK$

Shares applied for

HK$

Shares applied for

HK$

申請認購的預留

申請時應繳款項

申請認購的預留

申請時應繳款項

申請認購的預留

申請時應繳款項

申請認購的預留

申請時應繳款項

股份數目

(港元)

股份數目

(港元)

股份數目

(港元)

股份數目

(港元)

100

5,838.25

2,500

145,956.13

30,000

1,751,473.52

600,000

35,029,470.36

200

11,676.49

3,000

175,147.35

40,000

2,335,298.02

700,000

40,867,715.42

300

17,514.74

3,500

204,338.58

50,000

2,919,122.53

800,000

46,705,960.48

400

23,352.98

4,000

233,529.80

60,000

3,502,947.04

900,000

52,544,205.54

500

29,191.23

4,500

262,721.03

70,000

4,086,771.54

1,000,000

58,382,450.60

600

35,029.47

5,000

291,912.25

80,000

4,670,596.05

1,500,000

87,573,675.90

700

40,867.71

6,000

350,294.70

90,000

5,254,420.55

2,000,000

116,764,901.20

800

46,705.96

7,000

408,677.15

100,000

5,838,245.06

2,500,000

145,956,126.50

900

52,544.20

8,000

467,059.60

200,00011,676,490.12

3,000,000

175,147,351.80

1,000

58,382.45

9,000

525,442.06

300,000

17,514,735.18

3,500,000

204,338,577.10

1,500

87,573.68

10,000

583,824.51

400,000

23,352,980.24

4,000,000

233,529,802.40

2,000

116,764.90

20,000

1,167,649.01

500,000

29,191,225.30

4,186,000

244,388,938.21

Write down the number of Reserved Shares you want to a

ly for and the total amount ayable in the following appropriate boxes in ink (preferably in black) and mark "X" in the corresponding boxes underneath.

請在以下適當空格內用墨水筆(以黑色為佳)填寫 閣下擬申請之預留股份數目及應繳總額,並在相應空格內加上「X」。

Number of Assured Entitlement applied for

Total amount of remittance (HK$)

申請保證配額數目

付款總額(港元)

,

,

,

,

,

,

.

0

0

,

0

0

0

,

0

0

0

,

0

0

0

0

0

0

,

0

0

0

,

0

0

0

,

0

0

0

.

0

0

1

1

,

1

1

1

,

1

1

1

,

1

1

1

1

1

1

,

1

1

1

,

1

1

1

,

1

1

1

.

1

1

2

2

,

2

2

2

,

2

2

2

,

2

2

2

2

2

2

,

2

2

2

,

2

2

2

,

2

2

2

.

2

2

3

3

,

3

3

3

,

3

3

3

,

3

3

3

3

3

3

,

3

3

3

,

3

3

3

,

3

3

3

.

3

3

4

4

,

4

4

4

,

4

4

4

,

4

4

4

4

4

4

,

4

4

4

,

4

4

4

,

4

4

4

.

4

4

5

5

,

5

5

5

,

5

5

5

,

5

5

5

5

5

5

,

5

5

5

,

5

5

5

,

5

5

5

.

5

5

6

6

,

6

6

6

,

6

6

6

,

6

6

6

6

6

6

,

6

6

6

,

6

6

6

,

6

6

6

.

6

6

7

7

,

7

7

7

,

7

7

7

,

7

7

7

7

7

7

,

7

7

7

,

7

7

7

,

7

7

7

.

7

7

8

8

,

8

8

8

,

8

8

8

,

8

8

8

8

8

8

,

8

8

8

,

8

8

8

,

8

8

8

.

8

8

9

9

,

9

9

9

,

9

9

9

,

9

9

9

9

9

9

,

9

9

9

,

9

9

9

,

9

9

9

.

9

9

You must pay for the Reserved Shares applied for pursuant to your Assured Entitlement by a separate cheque or banker's cashier order. 閣下必須以獨立開出的支票或銀行本票支付根據 閣下的保證配額所申請的預留股份。

* Cheque or banker's cashier order should be crossed "Account Payee Only" and made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS BIOTECH PREFERENTIAL OFFER". The

applicant's name/the first applicant's name on the joint application must be the same as the name pre-printed or certified/endorsed by a person authorised by the drawee bank on the cheque/banker's cashier order.

* 支票或銀行本票須以「只准入抬頭人賬戶」方式劃線開出,並須註明抬頭人為「中國銀行Sample( 香港) 代理人有限公司-復宏漢霖生物技術優先發售」。申請人名稱聯名申請的排名首位申請人名稱須與在支票銀行本

票的預印名稱或由銀行授權人士在支票銀行本票背書的名稱相同。

Cheque/Banker's cashier order number*

Signed by (all) applicant(s) (all joint applicants must sign):

支票銀行本票號碼*

由(所有)申請人簽署(所有聯名申請人必須簽署):

Name of bank on which cheque/banker's

cashier order is drawn*

支票銀行本票之付款銀行名稱*

Contact telephone no.

聯絡電話號碼

You (or, if you are joint applicants, the first-named applicant) must provide your Hong Kong identity card number/

passport number/Hong Kong business registration certificate number (Please delete as appropriate)

閣下或(倘 閣下為聯名申請人)排名首位申請人必須提供香港身份證號碼護照號碼香港商業登記

號碼(請刪除不適用者)

Date 日期:

................................... /................................... /...................................

D

M

Y

Excess

Application

ORANGE FORM 橙表(Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Please staple your payment here

請將股款

緊釘在此

This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company") dated 12 September 2019 (the "Prospectus").

本申請表格使用上海復宏漢霖生物技術股份有限公司(「本公司」)於二零一九年九月十二日刊發的招股章程(「招 股章程」)所界定的相同詞彙。

Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act.

本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根 據美國證券法登記或豁免登記,香港發售股份不得在美國提呈發售或出售。

This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in

any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under

the law of that jurisdiction.

任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得發送或派發或轉載(不論方 式,亦不論全部或部分)本申請表格及招股章程。

Copies of the Prospectus, all related Application Forms and the other documents specified in the "Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection - Documents Delivered to the Registrar of Companies" section in Appendix VII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), Hong Kong Securities Clearing Company Limited ("HKSCC"), the Securities and Futures Commission of Hong Kong (the "SFC") and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents.

招股章程、所有相關申請表格及招股章程附錄七「送呈香港公司註冊處處長及備查文件-送呈公司註冊處處長文 件」一節所述的其他文件均已根據香港法例第32 章《公司(清盤及雜項條文)條例》第342C 條規定送呈香港公司註 冊處處長辦理登記。香港交易及結算所有限公司、香港聯合交易所有限公司(「聯交所」)、香港中央結算有限公司 (「香港結算」)、香港證券及期貨事務監察委員會(「證監會」)及香港公司註冊處處長對此等文件的內容概不負責。

Shanghai H nlius Biot ch, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

(A joint stock company incorporated in the P

op 's R public of China with limited liability)

(於中華人民共和國註冊成立的股份有限公司)

Stock code

:

2696

股份代號 :

2696

Maximum Offer Price

:

HK$57.80 per Offer Share, plus brokerage fee of

1%, SFC transaction levy of 0.0027% and Stock

Exchange trading fee of 0.005% (payable in full

on application in Hong Kong dollars, subject to

refund)

最高發售價 : 每股發售股份57.80 港元,另加1% 經紀佣金、

0.0027% 證監會交易徵費及0.005% 聯交所交

易費(須於申請時以港元繳足,多繳款項可予退

還)

Applic nts' decl r tion

申請人聲明

I/We agree to the terms nd conditions and application

本人吾等同意本申請表格及招股章程的條款及

procedures in this Application Form and the

條件以及申請程序。請參閱本申請表格「丁. 填交

Prospectus. Please refer to the "D. Effect of completing

本申請表格的效用」一節。

and submitting this Application Form" section of this

Application Form.

Sample

Warning: Only one application may be made for

警告:任何人士僅可為本身利益以色申請表格

the benefit of any person for excess Reserved Shares

就超額預留股份作出一次申請。下列情況將不獲

on an ORANGE Application Form. The following

受理:就超額預留股份作出的重複或疑屬重複申

are liable to be rejected: multiple or suspected

請以及支票或銀行本票在首次過戶時未能兌現的

multiple applications for excess Reserved Shares and

申請。

applications where cheques or banker's cashier orders

are dishonoured upon the first presentation.

Name(s) and address of the Qualifying Fosun International Shareholder 合資格復星國際股東姓名╱名稱及地址

Excess

Application

ORANGE FORM 橙表(Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

User ID 使用者編號

Access Code 通行編號

CCS6536

Apply for Excess Reserved Shares

Other than your Assured Entitlement, you may apply for excess Reserved Shares. If you intend to apply for excess Reserved Shares, you MUST apply for a number of excess Reserved Shares which is one of the numbers set out in the table below (other than HKSCC Nominees). If you intend to apply for a number of excess Reserved Shares which is not one of the numbers set out in the table below, you MUST apply by using Orange Form eIPO only. If you wish to apply for excess Reserved Shares in addition to your Assured Entitlement, you should complete and sign the ORANGE Application Form for excess Reserved Shares and lodge it, together with a separate remittance for the full amount payable on application in respect of the excess Reserved Shares applied for or apply through the Orange Form eIPO service via www.eipo.com.hk.

You need to complete and sign this Application Form and submit one cheque (or banker' s cashier order) for the exact amount of remittance in the table below.

申請超額預留股份

除保證配額外, 閣下亦可申請超額預留股份。倘 閣下擬申請超額預留股份, 閣下必須申請下表中載列的其中一個 超額預留股份數目(香港結算代理人除外)。倘 閣下擬申請不在下表中載列的其中一個超額預留股份數目, 閣下必 須用橙表eIPO 申請。倘 閣下擬申請保證配額以外的超額預留股份,則須填妥並簽署申請超額預留股份之橙色申請 表格,並單獨匯款足額支付所申請超額預留股份的應付股款,或透過www.eipo.com.hk使用橙表eIPO 服務遞交申請。 閣下須填妥及簽署本申請表格並提交一張支票(或銀行本票)支付下表中載列的應付確切金額

NUMBER OF EXCESS RESERVED SHARES THAT MAY BE APPLIED FOR AND PAYMENTS

可供申請認購的超額預留股份數目及款項

Amount payable

Amount payable

Amount payable

Amount payable

No. of Reserved

on application

No. of Reserved

on application

No. of Reserved

on application

No. of Reserved

on application

Shares applied for

HK$

Shares applied for

HK$

Shares applied for

HK$

Shares applied for

HK$

申請認購的預留

申請時應繳款項

申請認購的預留

申請時應繳款項

申請認購的預留

申請時應繳款項

申請認購的預留

申請時應繳款項

股份數目

(港元)

股份數目

(港元)

股份數目

(港元)

股份數目

(港元)

100

5,838.25

2,500

145,956.13

30,000

1,751,473.52

600,000

35,029,470.36

200

11,676.49

3,000

175,147.35

40,000

2,335,298.02

700,000

40,867,715.42

300

17,514.74

3,500

204,338.58

50,000

2,919,122.53

800,000

46,705,960.48

400

23,352.98

4,000

233,529.80

60,000

3,502,947.04

900,000

52,544,205.54

500

29,191.23

4,500

262,721.03

70,000

4,086,771.54

1,000,000

58,382,450.60

600

35,029.47

5,000

291,912.25

80,000

4,670,596.05

1,500,000

87,573,675.90

700

40,867.71

6,000

350,294.70

90,000

5,254,420.55

2,000,000

116,764,901.20

800

46,705.96

7,000

408,677.15

100,000

5,838,245.06

2,500,000

145,956,126.50

900

52,544.20

8,000

467,059.60

200,000

11,676,490.12

3,000,000

175,147,351.80

1,000

58,382.45

9,000

525,442.06

3,500,000

204,338,577.10

300,000

17,514,735.18

1,500

87,573.68

10,000

583,824.51

400,000

23,352,980.24

4,000,000

233,529,802.40

2,000

116,764.90

20,000

1,167,649.01

500,000

29,191,225.30

4,186,000

244,388,938.21

Sample

Write down the number of excess Reserved Shares you want to a ly for and the total amount ayable in the following appropriate boxes in ink (preferably in black) and mark "X" in the corresponding boxes underneath.

請在以下適當空格內用墨水筆(以黑色為佳)填寫

閣下擬申請之超額預留股份數目及應繳總額,並在相應空格內加上「X」。

Number of excess Reserved Shares applied for

Total amount of remittance (HK$)

申請超額預留股份數目

付款總額(港元)

,

,

,

,

,

,

.

0

0

,

0

0

0

,

0

0

0

,

0

0

0

0

0

0

,

0

0

0

,

0

0

0

,

0

0

0

.

0

0

1

1

,

1

1

1

,

1

1

1

,

1

1

1

1

1

1

,

1

1

1

,

1

1

1

,

1

1

1

.

1

1

2

2

,

2

2

2

,

2

2

2

,

2

2

2

2

2

2

,

2

2

2

,

2

2

2

,

2

2

2

.

2

2

3

3

,

3

3

3

,

3

3

3

,

3

3

3

3

3

3

,

3

3

3

,

3

3

3

,

3

3

3

.

3

3

4

4

,

4

4

4

,

4

4

4

,

4

4

4

4

4

4

,

4

4

4

,

4

4

4

,

4

4

4

.

4

4

5

5

,

5

5

5

,

5

5

5

,

5

5

5

5

5

5

,

5

5

5

,

5

5

5

,

5

5

5

.

5

5

6

6

,

6

6

6

,

6

6

6

,

6

6

6

6

6

6

,

6

6

6

,

6

6

6

,

6

6

6

.

6

6

7

7

,

7

7

7

,

7

7

7

,

7

7

7

7

7

7

,

7

7

7

,

7

7

7

,

7

7

7

.

7

7

8

8

,

8

8

8

,

8

8

8

,

8

8

8

8

8

8

,

8

8

8

,

8

8

8

,

8

8

8

.

8

8

9

9

,

9

9

9

,

9

9

9

,

9

9

9

9

9

9

,

9

9

9

,

9

9

9

,

9

9

9

.

9

9

You must pay for the excess Reserved Shares applied for by a separate cheque or banker's cashier order. 閣下必須以獨立開出的支票或銀行本票支付所申請的超額預留股份。

* Cheque or banker' s cashier order should be crossed "Account Payee Only" and made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS BIOTECH PREFERENTIAL OFFER". The applicant's name/the first applicant's name on the joint application must be the same as the name pre-printed or certified/endorsed by a person authorised by the drawee bank on the cheque/banker's cashier order.

* 支票或銀行本票須以「只准入抬頭人賬戶」方式劃線開出,並須註明抬頭人為「中國銀行( 香港) 代理人有限公司-復宏漢霖生物技術優先發售」。申請人名稱聯名申請的排名首位申請人名稱須與在支票銀行本

票的預印名稱或由銀行授權人士在支票銀行本票背書的名稱相同。

Cheque/Banker's cashier order number*

Signed by (all) applicant(s) (all joint applicants must sign):

支票銀行本票號碼*

由(所有)申請人簽署(所有聯名申請人必須簽署):

Name of bank on which cheque/banker's

cashier order is drawn*

支票銀行本票之付款銀行名稱*

Contact telephone no.

聯絡電話號碼

You (or, if you are joint applicants, the first-named applicant) must provide your Hong Kong identity card number/

passport number/Hong Kong business registration certificate number (Please delete as appropriate)

閣下或(倘 閣下為聯名申請人)排名首位申請人必須提供香港身份證號碼護照號碼香港商業登記

號碼(請刪除不適用者)

Date 日期:

................................... /................................... /...................................

D

M

Y

AssuredEntitlement配額

保證

ORANGE FORM 橙表(Assured Entitlement 保證配額)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Application Form for Assured Entitlement of Qualifying Fosun International Shareholders

合 資 格 復 星 國 際 股 東 保 證 配 額 申 請 表 格

For Qualifying Fosun International Shareholders,

合資格復星國際股東的

applications will be accepted until 12:00 noon

截止接受申請時間

on Tuesday, 17 September 2019.

為二零一九年九月十七日

You must read the conditions and instructions

(星期二)中午十二時正。

attached to this Application Form.

閣下務必細閱本申請表格隨附的

To be valid, you must complete all applicable parts

條件及指示。

of this Application Form.

本申請表格各適用部分必須以英文用墨水筆或

Please write clearly in English and in ink.

原子筆清楚填妥,方為有效。

Mixed Media Offer

混合媒介要約

The Company will be relying on Section 9A of the Companies

本公司將依據香港法例第32L 章《公司(豁免公司及招股

(Exemption of Companies and Prospectuses from Compliance

章程遵從條文)公告》第9A 條,在(i) 並非與招股章程印

with Provisions) Notice (Chapter 32L of the Laws of Hong

刷本一併發出的情況下,發出白色黃色申請表格;及

Kong) and will be issuing the (i) WHITE and YELLOW

(ii) 並非與招股章程印刷本一併發出的情況下,向相關

Application Forms without them being accompanied by a

合資格復星國際股東發出橙色申請表格及向相關合資格

printed Prospectus; and (ii) the ORANGE Application Forms

復星醫藥H 股股東發出藍色申請表格,除非相關合資格

to the relevant Qualifying Fosun International Shareholders and

復星國際股東或相關合資格復星醫藥H 股股東(視情況

the BLUE Application Forms to the relevant Qualifying Fosun

而定)已選擇根據復星國際或復星醫藥(視情況而定)公

Pharma H Shareholders without them being accompanied by

司通訊政策收取公司通訊印刷本或未被要求選擇收取復

a printed Prospectus, unless the relevant Qualifying Fosun

星國際或復星醫藥(視情況而定)公司通訊稿的方式,在

International Shareholders or the relevant Qualifying Fosun

此情況下,招股章程印刷本會分開寄發予彼等。招股章

Pharma H Shareholders (as the case may be) have el ct d to

程的印刷本的內容與招股章程的電子版本相同,招股章

receive corporate communications in printed form und r the

程的電子版本分別在本公司網站www.henlius.com及聯

corporate communications policy of Fosun International or

交所網站www.hkexnews.hk披露易>上市公司公告>

Fosun Pharma (as the case may be), or have not been ask d to

最新上市公司公告」一欄中可供查閱及下載。

elect the means of receiving the corporate communications of

Fosun International or Fosun Pharma (as the case may b ), in

which case the printed Prospectus will be des atched to them

separately. The contents of the printed Pros ectus are identical

to the electronic version of the Pros ectus which can be

accessed and downloaded from the websites of the Com any at

www.henlius.comand the Stock Exchange at www.hkexnews.

hkunder the "HKExnews > Listed Co

any Infor ation >

Latest Listed Company Infor ation " section, respectively.

Members of the public, the Qualifying Fosun International

有意索取招股章程印刷本的公眾人士、合資格復星國

Shareholders and the Qualifying Fosun Phar a H Shareholders

際股東及合資格復星醫藥H 股股東可於二零一九年九月

who wish to obt in

copy of the printed Prospectus ay obtain a

十二日(星期四)上午九時正至二零一九年九月十七日

copy, free of ch rge, upon request during nor al business hours

(星期二)中午十二時正的正常辦公時間內,在以下地點

from 9:00 .m. on Thursd y, 12 Septe

ber 2019 until 12:00

免費索取:

noon on Tuesd y, 17 September 2019 t the following locations:

1. any of the following br nches of the receiving banks of the

1. 本公司收款銀行的下列任何分行:

Comp ny:

Bank of China (Hong Kong) Limited

中國銀行(香港)有限公司

District

Branch Name

Address

地區

分行名稱

地址

Hong Kong Island

Des Voeux Road

111-119 Des Voeux Road West,

香港島

德輔道西分行

香港德輔道西

West Branch

Hong Kong

111-119

Chai Wan Branch

Block B, Walton Estate,

柴灣分行

香港

Sample341-343 Chai Wan Road,

柴灣道341-343

Chai Wan,

宏德居B

Hong Kong

Kowloon

Telford Plaza Branch

Shop Unit P2-P7,

九龍

德福廣場分行

九龍灣

Telford Plaza,

偉業街33

No.33 Wai Yip Street,

德福廣場

Kowloon Bay,

P2-P7號舖

Kowloon

AssuredEntitlement配額

保證

ORANGE FORM 橙表(Assured Entitlement 保證配額)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Olympian City Branch

Shop 133, 1/F,

奧海城分行

九龍

Olympian City 2,

海庭道18

18 Hoi Ting Road,

奧海城二期一樓

Kowloon

133

New Territories

Metro City Branch

Shop 209, Level 2,

新界

新都城分行

新界

Metro City Phase 1,

將軍澳

Tseung Kwan O,

新都城一期二樓

New Territories

209

Ma On Shan Plaza

Shop 2103, Level 2,

馬鞍山廣場分行

新界

Branch

Ma On Shan Plaza,

馬鞍山

Sai Sha Road,

西沙路

Ma On Shan,

馬鞍山廣場L2

New Territories

2103

CMB Wing Lung Bank Limited

招商永隆銀行有限公司

地址

District

Branch Name

Address

地區

分行名稱

Hong Kong Island

Head Office

45 Des Voeux Road Central

香港島

總行

德輔道中45

Kennedy Town Branch

28 Catchick Street

堅尼地城分行

吉席街28

Kowloon

Mongkok Branch

B/F CMB

九龍

旺角分行

彌敦道636

Wing Lung Bank Centre,

招商永隆

636 Nathan Road

銀行中心地庫

Tsim Sha Tsui Branch

4 Carnarvon Road

尖沙咀分行

加拿分道4

Sample

新界

荃灣分行

沙咀道251

New Territories

Tsuen Wan Branch

251 Sha Tsui Road

2. any of the following offices of

the below Joint G obal

2. 以下聯席全球協調人的下列任何辦事處:

Coordinators:

China International Capital Corporation Hong Kong

中國國際金融香港證券有限公司

Securities Limited

香港

29th Floor, One International Finance Centre

中環

1 Harbour View Street

港景街1

Central

國際金融中心一期29

Hong Kong

Merrill Lynch (Asia Pacific) Limited

Merrill Lynch (Asia Pacific) Limited

Level 55 Cheung Kong Center

香港

2 Queen's Road Central

中環

Central

皇后大道中2

Hong Kong

長江集團中心55

BOCI Asia Li

ited

中銀國際亞洲有限公司

26th Floor, B nk of China Tower

香港

1 G rden Ro d

中環

Centr l

花園道1

Hong Kong

中銀大廈26

UBS AG Hong Kong Br nch

UBS AG Hong Kong Branch

52/F, Two International Finance Centre

香港

8 Finance treet

中環

Central

金融街8

Hong Kong

國際金融中心二期52

CMB International Capital Limited

招銀國際融資有限公司

45/F, Champion Tower

香港

3 Garden Road

中環

Central

花園道3

Hong Kong

冠君大廈45

Fosun Hani Securities Limited

復星恆利證券有限公司

Suite 2101-2105 21/F Champion Tower

香港

3 Garden Road

中環

Central

花園道3

Hong Kong

冠君大廈21 2101-2105

3. the Depository Counter of HKSCC at 1/F, One & Two Exchange Square, 8 Connaught Place, Central, Hong Kong.
Details of where printed Prospectuses may be obtained will be displayed prominently at every designated branch of receiving banks where WHITE Application Forms are distributed.
During normal business hours from 9:00 a.m. on Thursday, 12 September 2019 until 12:00 noon on Tuesday, 17 September 2019, at least three copies of the printed Prospectus will be available for inspection at every location where the WHITE and YELLOW Application Forms are distributed as set out in the section headed "How to Apply for Hong Kong Offer Shares and Reserved Shares" in the Prospectus.

AssuredEntitlement配額

保證

ORANGE FORM 橙表(Assured Entitlement 保證配額)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

3. 香港結算存管處服務櫃檯,地址為香港中環康樂廣 場8 號交易廣場一座及二座一樓。

可索取招股章程印刷本的地址詳情將於派發白色申請表 格的收款銀行各指定分行以顯眼方式展示。

於二零一九年九月十二日(星期四)上午九時正至二零 一九年九月十七日(星期二)中午十二時正的正常辦公時 間內,在派發白色黃色申請表格的各個地點(載於招 股章程「如何申請香港發售股份及預留股份」),均有至 少三份招股章程印刷本可供查閱。

To: Shanghai Henlius Biotech, Inc.

致: 上海復宏漢霖生物技術股份有限公司

Joint Sponsors

聯席保薦人

Joint Global Coordinators

聯席全球協調人

Joint Representatives

聯席代表

Joint Bookrunners

聯席賬簿管理人

Hong Kong Underwriters

香港包銷商

I/We:

本人╱我們:

Sample

being the Qualifying Fosun International Shareholder(s) named

乃名列本申請表格之合資格復星國際股東,按照招股章

on this Application Form, apply for the number of R s rv d

程及本申請表格所載條款及條件以及在 貴公司章程細

Shares specified or deemed to be specified, on the t rms and

則規限下,申請所指定或視作指定數目之預留股份;

conditions of the Prospectus and this Application Form, and

subject to the Articles of Association of the Company;

enclose payment in full for the Reserved Shares app i d for

隨附以最高發售價每股發售股份57.80 港元(多繳款項可

at the Maximum Offer Price of HK$57.80 per Off r Share

予退還)計算申請認購預留股份所需的全數付款(包括

(subject to refund), including a 1% brokerage fee, a 0.0027%

1% 經紀佣金、0.0027% 證監會交易徵費及0.005% 聯交

SFC transaction levy and a 0.005% Stock Exchange trading

所交易費);

fee;

undertake and agree to accept the Reserved Shares a lied

承諾同意接納本人我們就本申請所申請認購的預留

for, or any lesser number allotted to me/us on this a

lication;

股份,或獲配發的任何較少數目;

warrant that this is the

only a lication ade

by me/us

保證是項申請乃本人我們就預留股份為本人我們本

for Reserved Shares for

y/our own benefit (other than an

身利益作出之唯一申請(除以合資格復星醫藥H 股股東

application (if any) ade in the capacity as a Qualifying Fosun

身份作出的申請(如有)外);

Pharma H Shareholder);

underst nd nd confirm th t these declarations and

明白確認

貴公司及聯席代表將依賴該等聲明及陳

represent tions will be relied upon by the Co pany and the

述,以決定是否就本申請向本人我們配發任何預留股

Joint Represent tives in deciding whether or not to

ake any

份,而本人我們如果作出虛假聲明可能會被檢椌;

allotment of Reserved Sh res to me/ us in response to this

applic tion nd th t I/we m y be prosecuted for making a false

declar tion;

authorise the Company to place my/our name(s) on the H

授權 貴公司將本人我們的姓名名稱列入H 股股東

hare register as the holder(s) of any Reserved Shares to be

名冊內,作為將配發予本人我們的任何預留股份的持

allotted to me/us and such other registers as required under

有人,及根據

貴公司章程細則規定的其他登記冊內,

the Articles of Association of the Company, and despatch

並按本申請表格上所示地址以普通郵遞方式向本人

any Share certificate(s) (where applicable) and/or any refund

我們寄發任何股票(如適用)及或任何退款支票(如適

cheque(s) (where applicable) to me/us by ordinary post at my/

用),郵誤風險概由本人我們自行承擔(除非本人

our own risk to the address stated in this Application Form

們申請1,000,000 股或以上預留股份,且本人我們符

unless I/ we have applied for 1,000,000 Reserved Shares or

合資格按本申請表格規定親自領取任何股票及或任何

more and I/we am/are eligible to collect any Share certificate(s)

退款支票(如適用));

and/or any refund cheque (where applicable) personally, as provided in this Application Form;

  • undertake to sign all documents and to do all things necessary to enable me/us to be registered as the holder of the Reserved Shares to be allocated to me/us, and as required by the Articles of Association of the Company;

承諾簽署所有文件並採取所有必要的事宜,以及根 據 貴公司章程細則規定讓本人我們登記為本人我 們獲分配的預留股份的持有人;

AssuredEntitlement配額

保證

ORANGE FORM 橙表(Assured Entitlement 保證配額)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

  • request that any refund cheque(s) be made payable to me/ 要求任何退款支票以本人本申請表格內我們的排名首

the first-named of us (in the case of joint applicants) in this 位者(倘屬聯名申請人)為抬頭人; Application Form;

have read the terms and conditions and application procedures

細閱本申請表格隨附各頁及招股章程所載的條款和條

set out on the pages attached to this Application Form and in

件及申請程序,並同意受其約束且知悉招股章程所述有

the Prospectus and agree to be bound by them, and am aware

關優先發售的限制;

of the restrictions on the Preferential Offering described in the

Prospectus;

represent, warrant and undertake that the allotment of, or

聲明保證承諾獲配發或申請認購預留股份不會引

application for, the Reserved Shares would not require the

致 貴公司、聯席保薦人、聯席全球協調人、聯席代

Company, the Joint Sponsors, the Joint Global Coordinators,

表、聯席賬簿管理人、聯席牽頭經辦人或包銷商須遵從

the Joint Representatives, the Joint Bookrunners, the Joint Lead

香港以外任何地區的任何法律或法規的任何規定(不論

Managers or the Underwriters to comply with any requirements

是否具法律效力);

under any law or regulation (whether or not having the force of

law) of any territory outside Hong Kong;

represent, warrant and undertake that I am not/ we are not

聲明保證承諾本人我們並非香港或其他地區任何

restricted by any applicable laws of Hong Kong or elsewhere

適用法律規定不得作出是項申請、支付任何申請款項或

from making this application, paying any application monies

獲配發或接納任何預留股份的受限制人士;及本人

for, or being allotted or taking up any Reserved Shares; that I/

們明白預留股份並無亦不會根據美國證券法登記;本人

we understand that the Reserved Shares have not been and will

我們將在「離岸交易」(定義見美國證券法S 規例)中購

not be registered under the U.S. Securities Act; and that I/we

買預留股份;及

will acquire the Reserved Shares in an "offshore transaction"

(within the meaning of Regulation S under the U.S. S curiti s

Act); and

agree that this application, any acceptance of it and the

同意本申請、任何對本申請的接納以及因此訂立的合

resulting contract, will be governed by and constru d in

約,將受香港法例規管及按其詮釋。

accordance with the laws of Hong Kong.

Warning:

警告:

It is important that you read the terms and conditions and

閣下必須細閱招股章程及本申請表格所載的條款和條

application procedures set out in the Pros ectus and in this

件及申請程序。

Application Form.

You must sign this application in writing (and not by way

閣下必須以書面方式(不得以個人印章方式)簽署本申

of personal chop), otherwise the a lication is liable to be

請,否則申請會被拒絕受理。

rejected.

Only one application ay be ade for the benefit of any

任何人士僅可為本身利益以橙色申請表格就預留股份

person for Reserved Shares on an ORANGE Application

作出一次申請。下列情況將不獲受理:於橙色申請表

Form. The following re li ble to be rejected: ultiple or

格或透過橙表eIPO 服務就預留股份作出的重複或疑屬

suspected multiple pplic tions for Reserved Shares on the

重複申請以及支票或銀行本票在首次過戶時未能兌現

ORANGE Applic tion Form or through Orange Form

的申請。

eIPO service nd pplic tions where cheques or banker's

cashier orders re dishonoured upon the first presentation.

You m y be prosecuted if you m ke a false declaration.

倘 閣下作出虛假聲明,則可遭檢控。

All information stated in this Application Form must be the

在本申請表格中聲明的所有資料必須與復星國際或其

same as that maintained by Fosun International or any of its

任何全資附屬公司所保存者相同。

wholly-owned subsidiaries.

You must complete this application in English (except

除中文姓名名稱外, 閣下必須以英文填妥本申請

Chinese name) unless otherwise stated, otherwise the

(除非另有指明),否則申請會被拒絕受理。

Sampleapplication is liable to be rejected.

Any alteration to any application detail that you provide on

閣下於本申請表格提供的任何申請資料如有任何更

this Application Form should be authorised by the signature

改,須由申請人簽署授權。

of the applicant.

  • You or, if you are joint applicants, the first-named applicant must provide your Hong Kong identity card number/ passport number/Hong Kong business registration certificate number.

閣下或(倘 閣下為聯名申請人)排名首位申請人必須 提供香港身份證號碼護照號碼香港商業登記號碼。

Excess

Application

ORANGE FORM 橙表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Application Form for Excess Reserved Shares of Qualifying Fosun International Shareholders

合 資 格 復 星 國 際 股 東 超 額 預 留 股 份 申 請 表 格

For Qualifying Fosun International Shareholders,

合資格復星國際股東的

applications will be accepted until 12:00 noon.

截止接受申請時間

on Tuesday, 17 September 2019.

為二零一九年九月十七日

You must read the conditions and instructions

(星期二)中午十二時正。

attached to this Application Form.

閣下務必細閱本申請表格隨附的

To be valid, you must complete all applicable parts

條件及指示。

of this Application Form.

本申請表格各適用部分必須以英文用墨水筆或

Please write clearly in English and in ink.

原子筆清楚填妥,方為有效。

Mixed Media Offer

混合媒介要約

The Company will be relying on Section 9A of the Companies

本公司將依據香港法例第32L 章《公司(豁免公司及招股

(Exemption of Companies and Prospectuses from Compliance

章程遵從條文)公告》第9A 條,在(i) 並非與招股章程印

with Provisions) Notice (Chapter 32L of the Laws of Hong

刷本一併發出的情況下,發出白色黃色申請表格;及

Kong) and will be issuing the (i) WHITE and YELLOW

(ii) 並非與招股章程印刷本一併發出的情況下,向相關

Application Forms without them being accompanied by a

合資格復星國際股東發出橙色申請表格及向相關合資格

printed Prospectus; and (ii) the ORANGE Application Forms

復星醫藥H 股股東發出藍色申請表格,除非相關合資格

to the relevant Qualifying Fosun International Shareholders and

復星國際股東或相關合資格復星醫藥H 股股東(視情況

the BLUE Application Forms to the relevant Qualifying Fosun

而定)已選擇根據復星國際或復星醫藥(視情況而定)公

Pharma H Shareholders without them being accompanied by

司通訊政策收取公司通訊印刷本或未被要求選擇收取復

a printed Prospectus, unless the relevant Qualifying Fosun

星國際或復星醫藥(視情況而定)公司通訊稿的方式,在

International Shareholders or the relevant Qualifying Fosun

此情況下,招股章程印刷本會分開寄發予彼等。招股章

Pharma H Shareholders (as the case may be) have el ct d to

程的印刷本的內容與招股章程的電子版本相同,招股章

receive corporate communications in printed form und r the

程的電子版本分別在本公司網站www.henlius.com及聯

corporate communications policy of Fosun International or

交所網站www.hkexnews.hk披露易>上市公司公告>

Fosun Pharma (as the case may be), or have not been ask d to

最新上市公司公告」一欄中可供查閱及下載。

elect the means of receiving the corporate communications of

Fosun International or Fosun Pharma (as the case may b ), in

which case the printed Prospectus will be des atched to them

separately. The contents of the printed Pros ectus are identical

to the electronic version of the Pros ectus which can be

accessed and downloaded from the websites of the Com any at

www.henlius.comand the Stock Exchange at www.hkexnews.

hkunder the "HKExnews > Listed Co

any Infor ation >

Latest Listed Company Infor ation " section, respectively.

Members of the public, the Qualifying Fosun International

有意索取招股章程印刷本的公眾人士、合資格復星國

Shareholders nd the Qu lifying Fosun Phar a H Shareholders

際股東及合資格復星醫藥H 股股東可於二零一九年九月

who wish to obt in

copy of the printed Prospectus ay obtain a

十二日(星期四)上午九時正至二零一九年九月十七日

copy, free of ch rge, upon request during nor al business hours

(星期二)中午十二時正的正常辦公時間內,在以下地點

from 9:00 .m. on Thursd y, 12 Septe

ber 2019 until 12:00

免費索取:

noon on Tuesd y, 17 September 2019 t the following locations:

1. any of the following br nches of the receiving banks of the

1. 本公司收款銀行的下列任何分行:

Comp ny:

Bank of China (Hong Kong) Limited

中國銀行(香港)有限公司

District

Branch Name

Address

地區

分行名稱

地址

Hong Kong Island

Des Voeux Road

111-119 Des Voeux Road West,

香港島

德輔道西分行

香港德輔道西

West Branch

Hong Kong

111-119

Chai Wan Branch

Block B, Walton Estate,

柴灣分行

香港

Sample

柴灣道341-343

341-343 Chai Wan Road,

Chai Wan,

宏德居B

Hong Kong

Kowloon

Telford Plaza Branch

Shop Unit P2-P7,

九龍

德福廣場分行

九龍灣

Telford Plaza,

偉業街33

No.33 Wai Yip Street,

德福廣場

Kowloon Bay,

P2-P7號舖

Kowloon

Excess

Application

ORANGE FORM 橙表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Olympian City Branch

Shop 133, 1/F,

奧海城分行

九龍

Olympian City 2,

海庭道18

18 Hoi Ting Road,

奧海城二期一樓

Kowloon

133

New Territories

Metro City Branch

Shop 209, Level 2,

新界

新都城分行

新界

Metro City Phase 1,

將軍澳

Tseung Kwan O,

新都城一期二樓

New Territories

209

Ma On Shan Plaza

Shop 2103, Level 2,

馬鞍山廣場分行

新界

Branch

Ma On Shan Plaza,

馬鞍山

Sai Sha Road,

西沙路

Ma On Shan,

馬鞍山廣場L2

New Territories

2103

CMB Wing Lung Bank Limited

招商永隆銀行有限公司

地址

District

Branch Name

Address

地區

分行名稱

Hong Kong Island

Head Office

45 Des Voeux Road Central

香港島

總行

德輔道中45

Kennedy Town Branch

28 Catchick Street

堅尼地城分行

吉席街28

Kowloon

Mongkok Branch

B/F CMB

九龍

旺角分行

彌敦道636

Wing Lung Bank Centre,

招商永隆

636 Nathan Road

銀行中心地庫

Tsim Sha Tsui Branch

4 Carnarvon Road

尖沙咀分行

加拿分道4

Sample

新界

荃灣分行

沙咀道251

New Territories

Tsuen Wan Branch

251 Sha Tsui Road

2. any of the following offices of

the below Joint Global

2. 以下聯席全球協調人的下列任何辦事處:

Coordinators:

China International Capital Corporation Hong Kong

中國國際金融香港證券有限公司

Securities Limited

香港

29th Floor, One International Finance Centre

中環

1 Harbour View Street

港景街1

Central

國際金融中心一期29

Hong Kong

Merrill Lynch (Asia Pacific) Limited

Merrill Lynch (Asia Pacific) Limited

Level 55 Cheung Kong Center

香港

'

中環

2 Queen s Road Central

Central

皇后大道中2

Hong Kong

長江集團中心55

BOCI Asia Li

ited

中銀國際亞洲有限公司

26th Floor, B nk of China Tower

香港

1 G rden Ro d

中環

Centr l

花園道1

Hong Kong

中銀大廈26

UBS AG Hong Kong Br nch

UBS AG Hong Kong Branch

52/F, Two Intern tion l Fin nce Centre

香港

8 Finance treet

中環

Central

金融街8

Hong Kong

國際金融中心二期52

CMB International Capital Limited

招銀國際融資有限公司

45/F, Champion Tower

香港

3 Garden Road

中環

Central

花園道3

Hong Kong

冠君大廈45

Fosun Hani Securities Limited

復星恆利證券有限公司

Suite 2101-2105 21/F Champion Tower

香港

3 Garden Road

中環

Central

花園道3

Hong Kong

冠君大廈21 2101-2105

3. the Depository Counter of HKSCC at 1/F, One & Two Exchange Square, 8 Connaught Place, Central, Hong Kong.
Details of where printed Prospectuses may be obtained will be displayed prominently at every designated branch of receiving banks where WHITE Application Forms are distributed.

Excess

Application

ORANGE FORM 橙表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

3. 香港結算存管處服務櫃檯,地址為香港中環康樂廣 場8 號交易廣場一座及二座一樓。

可索取招股章程印刷本的地址詳情將於派發白色申請表 格的收款銀行各指定分行以顯眼方式展示。

During normal business hours from 9:00 a.m. on Thursday, 12

於二零一九年九月十二日(星期四)上午九時正至二零

September 2019 until 12:00 noon on Tuesday, 17 September

一九年九月十七日(星期二)中午十二時正的正常辦公時

2019, at least three copies of the printed Prospectus will be

間內,在派發白色黃色申請表格的各個地點(載於招

available for inspection at every location where the WHITE

股章程「如何申請香港發售股份及預留股份」),均有至

and YELLOW Application Forms are distributed as set out in

少三份招股章程印刷本可供查閱。

the section headed "How to Apply for Hong Kong Offer Shares

and Reserved Shares" in the Prospectus.

To: Shanghai Henlius Biotech, Inc.

致: 上海復宏漢霖生物技術股份有限公司

Joint Sponsors

聯席保薦人

Joint Global Coordinators

聯席全球協調人

Joint Representatives

聯席代表

Joint Bookrunners

聯席賬簿管理人

Hong Kong Underwriters

香港包銷商

I/We:

本人╱我們:

being the Qualifying Fosun International Shareholder(s) named

乃名列本申請表格之合資格復星國際股東,按照招股

on this Application Form, apply for the number of xc ss

章程及本申請表格所載條款及條件以及在 貴公司章程

Reserved Shares specified or deemed to be specified, on the

細則規限下,申請所指定或視作指定數目之超額預留股

terms and conditions of the Prospectus and this Application

份;

Form, and subject to the Articles of Association of the

Company;

enclose payment in full for the excess Reserved Shar s app i d

隨附以最高發售價每股發售股份57.80 港元(多繳款項可

for at the Maximum Offer Price of HK$57.80 per Off r Share

予退還)計算申請認購超額預留股份所需的全數付款(包

(subject to refund), including a 1% brokerage fee, a 0.0027%

1% 經紀佣金、0.0027% 證監會交易徵費及0.005%

SFC transaction levy and a 0.005% Stock Exchange trading

交所交易費);

fee;

undertake and agree to accept the excess Reserved Shares

承諾同意接納本人我們就本申請所申請認購的超額

applied for, or any lesser number allotted to me/us on this

預留股份,或獲配發的任何較少數目;

application;

warrant that this is the only application ade by e/us for

保證是項申請乃本人我們就超額預留股份為本人

excess Reserved Shares for y/our own benefit (other than an

們本身利益作出之唯一申請(除以合資格復星醫藥H

application (if any) ade in the capacity as a Qualifying Fosun

股東身份作出的申請(如有)外);

Pharma H Sh reholder);

underst nd nd confirm th t these declarations and

明白確認 貴公司及聯席代表將依賴該等聲明及陳

represent tions will be relied upon by the Co pany and the

述,以決定是否就本申請向本人我們配發任何超額預

Joint Represent tives in deciding whether or not to make any

留股份,而本人我們如果作出虛假聲明可能會被檢

allotment of excess Reserved Sh res to me/ us in response to

椌;

this applic tion nd th t I/we m y be prosecuted for making a

false decl r tion;

authorise the Company to place my/our name(s) on the H

授權 貴公司將本人我們的姓名名稱列入H 股股東

hare register as the holder(s) of any excess Reserved Shares

名冊內,作為將配發予本人我們的任何超額預留股份

to be allotted to me/us and such other registers as required

的持有人,及根據

貴公司章程細則規定的其他登記冊

under the Articles of Association of the Company, and

內,並按本申請表格上所示地址以普通郵遞方式向本人

despatch any Share certificate(s) (where applicable) and/or any

我們寄發任何股票(如適用)及或任何退款支票(如

Samplerefund cheque(s) (where applicable) to me/us by ordinary post 適用),郵誤風險概由本人我們自行承擔(除非本人

at my/ our own risk to the address stated in this Application

我們申請1,000,000 股或以上超額預留股份,且本人

Form unless I/we have applied for 1,000,000 excess Reserved

我們符合資格按本申請表格所述親自領取任何股票及

Shares or more and I/we am/are eligible to collect any Share

或任何退款支票(如適用));

certificate(s) and/or any refund cheque (where applicable)

personally, as provided in this Application Form;

undertake to sign all documents and to do all things necessary

承諾簽署所有文件並採取所有必要的事宜,以及根

to enable me/us to be registered as the holder of the excess

據 貴公司章程細則規定讓本人我們登記為本人

Reserved Shares to be allocated to me/ us, and as required by

們獲分配超額預留股份的持有人;

the Articles of Association of the Company;

Excess

Application

ORANGE FORM 橙表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun International Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

  • request that any refund cheque(s) be made payable to me/ 要求任何退款支票以本人本申請表格內我們的排名首

the first-named of us (in the case of joint applicants) in this 位者(倘屬聯名申請人)為抬頭人; Application Form;

have read the terms and conditions and application procedures

細閱本申請表格隨附各頁及招股章程所載的條款和條

set out on the pages attached to this Application Form and in

件及申請程序,並同意受其約束且知悉招股章程所述有

the Prospectus and agree to be bound by them, and am aware

關優先發售的限制;

of the restrictions on the Preferential Offering described in the

Prospectus;

represent, warrant and undertake that the allotment of,

聲明、保證承諾獲配發或申請認購超額預留股份不會

or application for, the excess Reserved Shares would not

引致 貴公司、聯席保薦人、聯席全球協調人、聯席代

require the Company, the Joint Sponsors, the Joint Global

表、聯席賬簿管理人、聯席牽頭經辦人或包銷商須遵從

Coordinators, the Joint Representatives, the Joint Bookrunners,

香港以外任何地區的任何法律或法規的任何規定(不論

the Joint Lead Managers or the Underwriters to comply with

是否具法律效力);

any requirements under any law or regulation (whether or not

having the force of law) of any territory outside Hong Kong;

represent, warrant and undertake that I am not/we are not

聲明、保證承諾本人我們並非香港或其他地區任何

restricted by any applicable laws of Hong Kong or elsewhere

適用法律規定不得作出是項申請、支付任何申請款項或

from making this application, paying any application monies

獲配發或接納任何超額預留股份的受限制人士;及本人

for, or being allotted or taking up any excess Reserved Shares;

我們明白超額預留股份並無亦不會根據美國證券法登

that I/we understand that the excess Reserved Shares have not

記;本人我們將在「離岸交易」(定義見美國證券法S

been and will not be registered under the U.S. Securities Act;

規例)中購買超額預留股份;及

and that I/we will acquire the excess Reserved Shares in an

"offshore transaction" (within the meaning of Regulation S

under the U.S. Securities Act); and

agree that this application, any acceptance of it and the

同意本申請、任何對本申請的接納以及因此訂立的合

resulting contract, will be governed by and constru d in

約,將受香港法例規管及按其詮釋。

accordance with the laws of Hong Kong.

Warning:

警告:

It is important that you read the terms and conditions and

閣下必須細閱招股章程及本申請表格所載的條款和條

application procedures set out in the Pros ectus and in this

件及申請程序。

Application Form.

You must sign this application in writing (and not by way

閣下必須以書面方式(不得以個人印章方式)簽署本申

of personal chop), otherwise the a

lication is liable to be

請,否則申請會被拒絕受理。

rejected.

Only one application ay be

ade for the benefit of

任何人士僅可為本身利益以橙色申請表格就超額預留

any person for excess Reserved Shares on an ORANGE

股份作出一次申請。下列情況將不獲受理:於橙色

Application Form. The following are liable to be rejected:

請表格或透過橙表eIPO 服務就超額預留股份作出的重

multiple or suspected ultiple applications for excess

複或疑屬重複申請以及支票或銀行本票在首次過戶時

Reserved Sh res on the ORANGE Application Form or

未能兌現的申請。

through Or nge Form eIPO service and applications where

cheques or b nker's c shier orders

re dishonoured upon the

first present tion.

You m y be prosecuted if you m ke a false declaration.

倘 閣下作出虛假聲明,則可遭檢控。

All inform tion st ted in this Application Form must be the

在本申請表格中聲明的所有資料必須與復星國際或其

same as that maintained by Fosun International or any of its

任何全資附屬公司所保存者相同。

wholly-owned subsidiaries.

You must complete this application in English (except

除中文姓名名稱外, 閣下必須以英文填妥本申請

Chinese name) unless otherwise stated, otherwise the

(除非另有指明),否則申請會被拒絕受理。

application is liable to be rejected.

Any alteration to any application detail that you provide on

閣下於本申請表格提供的任何申請資料如有任何更

Sample

this Application Form should be authorised by the signature

改,須由申請人簽署授權。

of the applicant.

  • You or, if you are joint applicants, the first-named applicant must provide your Hong Kong identity card number/ passport number/Hong Kong business registration certificate number.

閣下或(倘 閣下為聯名申請人)排名首位申請人必 須提供香港身份證號碼護照號碼香港商業登記號 碼。

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

Shanghai Henlius Biotech, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

GLOBAL OFFERING

Conditions of your Application

Orange Form eIPO service, the Company reserves the

Unless otherwise stated, terms used in these conditions have

right to permit any Fosun International Shareholder to

the same meanings ascribed thereto in the Prospectus.

take up his/her/its Assured Entitlement to the Reserved

A. Who can apply

Shares if the Company, in its absolute discretion, is

1. You, the applicant(s), and any person(s) for whose

satisfied that the transaction in question is exempt from

benefit you are applying, must be Qualifying Fosun

or not subject to the legislation or regulations giving rise

International Shareholder(s) and must be 18 years of

to the restrictions described above.

age or older .

5. The number of joint applicants may not exceed four.

2. If you are a firm, the application must be in the names

B. Allocation of Reserved Shares

of the individual members, not in the name of the

A valid application for a number of Reserved Shares that

firm.

is less than or equal to your Assured Entitlement will be

3. If you are a

body

corporate, the application must

accepted in full, subject to the terms and conditions set out

be stamped with the company chop (bearing the

in this Application Form and assuming that the conditions

company name) and signed by a duly authorised

of the Pr f r ntial Offering are satisfied. If an application

officer, who

must

state his or

her

repres

ntative

is made for a number of Reserved Shares that is less than

capacity.

your Assur d Entitlement, you MUST apply for a number

4. Save under

the

circumstances

permitted

by

the

in one of the numbers set out in the table of numbers and

Listing Rules and guidance letters issued by the Stock

paym nts in this Application Form and make a payment of

Exchange, or any relevant waivers that have b

n

the corr sponding amount (other than HKSCC Nominees).

granted by the Stock Exchange, you cannot a

y for

any Reserved Shares if you or (with the exce

tion of

If you intend to apply for a number of Assured Entitlement

which is not one of the numbers set out in the table in the

HKSCC Nominees) any person(s) for whose benefit

ORANGE Application Form for Assured Entitlement,

you are applying are/is:

you MUST apply by using Orange Form eIPO only. If

an existing beneficial owner

of

Shares in

the

you wish to apply for excess Reserved Shares in addition

Company and/or any of its subsidiaries;

to your Assured Entitlement, you should complete and

a director or chief executive of the Co

pany and/

sign the ORANGE Application Form for excess Reserved

or any of the Co

pany's subsidiaries;

Shares and lodge it, together with a separate remittance

an associate of any of the above persons;

for the full amount payable on application in respect of the

connected person of the Co

pany or a person

excess Reserved Shares applied for or apply for through

who will

beco

e

connected person

of

the

the

Orange Form eIPO service via www.eipo.com.hk.

Comp ny i

edi tely upon co

pletion of the

If an application is made for a number of Reserved Shares

Glob l Offering; or

that is greater than your Assured Entitlement, the relevant

Non-Qu lifying Fosun International Shareholder.

application for Assured Entitlement will be satisfied in

Non-Qu lifying

Fosun

International

Shareholders

full, but the application for excess Reserved Shares will

are those Fosun

International Shareholders with

only be met to the extent that there are sufficient Available

registered addresses in, or who are otherwise known

Reserved Shares. To the extent that excess applications for

by Fosun International to be residents of, jurisdictions

the Reserved Shares are:

outside Hong Kong on the Record Date, in respect

(i) less than the Available Reserved Shares, the Available

of whom the directors of Fosun International and

Reserved Shares will first be allocated to satisfy such

Samplethe Company, based on the enquiries made by them,

consider it necessary or expedient to exclude from the

excess applications for the Reserved Shares in full

Preferential Offering on

account

either of

the legal

and thereafter will be allocated, at the discretion of the

Joint Representatives, to the International Offering;

restrictions under the laws of the relevant jurisdiction

(ii)equal to the Available Reserved Shares, the Available

in which the relevant Fosun International Shareholder

Reserved Shares will be allocated to satisfy such

is resident or the

requirements of

the

relevant

excess applications for the Reserved Shares in full; or

regulatory body or stock exchange in that jurisdiction.

(iii) more than the Available Reserved Shares, the

Notwithstanding any other provision in the Prospectus or

Available Reserved Shares will be allocated on an

this Application Form or the terms and conditions of the

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

allocation basis which will be consistent with the D. Effect of completing and submitting this Application

allocation basis commonly used in the case of over-

Form

subscriptions in public offerings in Hong Kong, where

By completing and submitting this Application Form, you

a higher allocation percentage will be applied in

(and if you are joint applicants, each of you jointly and

respect of smaller applications. If there are any Shares

severally) for yourself or as an agent or a nominee and on

left after satisfying the excess applications, such

behalf of each person for whom you act as an agent or a

Shares will be re-allocated, at the discretion of the

nominee:

Joint Representatives, to the International Offering.

instruct

and authorise the

Company and/or Joint

No preference will be given to any excess applications

Representatives (or

their

respective agents

or

made to top up odd lot holdings to whole lot holdings

nominees), to execute

any

transfer forms, contract

of Shares.

notes or other documents on your behalf and to do

Save for the

above, the Preferential

Offering

will

not

on your

behalf all other things necessary to effect

be subject to the clawback arrangement between the

the registration of any Reserved Shares allocated to

International

Offering and

the Hong Kong

Public

you in your name(s) as required by the Articles of

Offering. Any application not accompanied by the correct

Association of the Company and otherwise to give

amount of application monies will be treated as invalid

in its entirety and no Reserved Shares will be allotted to

effect to the arrangements described in the Prospectus

and this Application Form;

such applicant.

undertake to sign

all documents and to do

all

In addition to any application for Reserved Shares made

things necessary to

enable

you to be registered

as

through the Orange Form eIPO service

via www.

the holder of the Reserved Shares allocated to you,

eipo.com.hkor on the ORANGE Application Forms,

and as required by the Articles of Association of the

Sample

Qualifying Fosun International Shareholders

will

be

Company;

entitled to make one application for Hong Kong Offer

r pr s nt, warrant

and

undertake that you

Shares on WHITE or YELLOW Application Forms or

und rstand that the Reserved Shares have not been

by giving electronic application instructions to HKSCC

and will not be registered under the U.S. Securities

via CCASS or by applying through the White Form

eIPO service.

Act; and that, with the exception of HKSCC

Qualifying Fosun International Shareholders wi

r c ive

Nomin

s, you or

any other person for whose

no preference as to entitlement or allocation in r s

ct

account or benefit you are acquiring Reserved Shares

of applications for Hong Kong Offer Shares made on

are outside the United States (within the meaning

WHITE or YELLOW Application Form or by giving

of Regulation S), and are a person described in

electronic application instructions to HKSCC or through

paragraph (h)(3) of Rule 902 of Regulation S;

the White Form eIPO service under the Hong Kong

confirm that you have only relied on the information

Public Offering.

and representations contained in the Prospectus in

Qualifying Fosun International Shareholders are entitled

making this application, and will not rely on any other

to apply on the basis of an Assured Entitle

ent of one

information or representation save as set out in any

Reserved Share for every integral

ultiple of 2,041

supplement to the Prospectus;

Fosun Intern tion l Sh res held by each Qualifying

agree that none of the Company, the Relevant

Fosun Intern tion l Sh reholder on the Record Date.

Persons or the Orange and Blue Form eIPO Service

Qualifying Fosun Intern tional Shareholders who

Provider is or will be liable for any information

hold less th n 2,041 Fosun International Shares on the

and representations

not in the Prospectus (and any

Record D te will not h ve

n Assured Entitlement to

supplement to it);

the Reserved

h res, but they will still be entitled to

agree (without prejudice to

any other rights which

particip te in

the

Preferenti l

Offering by applying

for

you may have) that once this application has been

excess Reserved

hares.

accepted, you may not rescind it due to an innocent

C. upplemental information

misrepresentation;

If any supplement to the Prospectus is issued, applicant(s)

(if the application is made by an agent on your

who have already submitted an application may or may

behalf) warrant that you have validly and irrevocably

not (depending on the information contained in the

conferred on your agent all necessary power and

supplement) be notified that they are required to confirm

authority to make this application;

their applications. If applicant(s) have been so notified

(if you are an agent for another person) warrant that

but have not confirmed their applications in accordance

reasonable enquiries have been made of the beneficial

with the procedure to be notified, all unconfirmed

owner that this application is the only application

applications will not be valid. Subject to the above, an

which will be made for the benefit of that other

application once made is irrevocable and applicants shall

person on a ORANGE Application Form and that

be deemed to have applied on the basis of the Prospectus

you are duly authorised to sign this Application Form

as supplemented.

as that other person's agent;

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

agree that once your application is accepted, your

understand that these declarations and representations

application will be evidenced by the results of the

will be relied upon by the Company and the Joint

Preferential Offering made available by the Company;

Representatives in deciding whether or not to allocate

warrant the truth and accuracy of the information

any Reserved Shares in response to your application;

contained in this application;

if the laws of any place outside Hong Kong are

agree to disclose to the Company, the H Share

applicable to your application, you agree and warrant

Registrar, the receiving banks, the Relevant Persons

that you have complied with all such laws and

and the Orange and Blue Form eIPO Service

none of the Company nor the Relevant Persons will

Provider any personal data about you or, with the

infringe any laws outside Hong Kong as a result of

exception of HKSCC Nominees, the person(s) for

the acceptance of your offer to purchase any Reserved

whose benefit you have made the application which

Shares, or any actions arising from your rights and

they require;

obligations under the terms and conditions contained

warrant that, in making an application, you or any

in the Prospectus;

person(s) on whose behalf you may be acting is/are

agree with the Company and for the benefit of each

Qualifying Fosun International Shareholder(s);

Shareholder (and so that the Company shall be

represent, warrant and undertake that in making

this application,

you and/or,

with

the exception of

deemed by their acceptance in whole or in part of this

HKSCC Nominees, any person(s) for whose behalf

application to have agreed, for itself and on behalf of

you may be acting are not connected person(s) or

each Shareholder) (and if applicable, with each CCASS

person(s) who will become connected person(s) of the

Participant giving

electronic application instructions),

Company immediately upon completion of the Global

and the Company agree with each Shareholder, to

Sample

Offering, the subscription for Reserved Shares by you

observe and comply with the Companies Ordinance

and/or, with the exception of HKSCC Nomin

s, any

(Chapter 622 of the Laws of Hong Kong), the

person(s) on whose behalf you may be acting is not

Compani s (Winding Up and Miscellaneous Provisions)

financed directly or indirectly by a connected p rson

Ordinance (Chapter 32 of the Laws of Hong Kong) and

of the Company, and you and/or, with the exc ption

the Articl s of Association of the Company;

of HKSCC Nominees, any person(s) on whose b ha f

agr with the Company and each Shareholder that

you may be

acting

is not

taking instructions from

the Shar s are freely transferable by the Shareholder;

a connected person of the Com any in making this

and

subscription for Reserved Shares;

understand that the Company and the Relevant

agree that your

application,

any

acce

tance of it

Persons are entitled to rely on any warranty,

and the resulting contract will be governed by and

representation or

declaration made by you in this

construed in accordance with the laws of Hong Kong;

application. In the event of the application being made

undertake and agree to acce

t the Reserved Shares

by joint applicants, all the warranties, representations,

applied for, or any lesser nu

ber

allocated

to you

declarations and

obligations expressed to be made,

under the application;

given or assumed by or imposed on the joint

authorise the Co pany to place your na

e(s) on

applicants shall be deemed to have been made, given

the Comp ny's H Sh re register of

e

bers as the

and assumed by and imposed on the applicants jointly

holder(s) of

ny Reserved Sh res allocated to you and

and severally. You may be prosecuted if you make a

such other registers

s required under the Co

pany's

false declaration.

Articles of

Associ tion,

nd despatch

any Share

You must complete this application in English,

certific te(s)

(where

pplic ble)

and/or

any

refund

unless otherwise stated, and you or (in case of joint

cheque(s) (where

pplic ble)

to

you or

(in

case of

applicants) each of the joint applicants must sign this

joint applicants) the first-named applicant in this

application in writing (and not by way of personal

Application Form by ordinary post at your own risk

chop), otherwise the application is liable to be

to the address stated on this Application Form (except

rejected.

if you have applied for 1,000,000 Reserved Shares or

E. Power of attorney

more you may collect your refund cheque and Share

If your application is made by a person, duly authorised

certificates (where applicable) in person);

under a valid power of attorney, the Company and the

agree that

the

processing

of

your application,

Joint Representatives, as the Company's agent, may

including the despatch of refund cheque(s) (if any),

accept it at their discretion and on any conditions they

may be done by any of the receiving banks and is not

think fit, including requiring evidence of the attorney's

restricted to the bank at which your Application Form

authority. The Company and the Joint Representatives, as

is lodged;

the Company's agents, will have full discretion to reject

confirm that you are aware of the restrictions on the

Preferential Offering of the Reserved Shares described

or accept any application, in full or in part without giving

in the Prospectus;

any reason.

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

F. Determination of Offer Price

If you apply for less than 1,000,000 Reserved Shares, your

The Offer Price is expected to be fixed on or around

refund cheque(s) and/or share certificate(s) will be sent to

Tuesday, 17 September 2019. Applicants are required

the address in your Application Form on or before Tuesday,

to pay the Maximum Offer Price of HK$57.80 for

24 September 2019, by ordinary post and at your own risk.

each Offer Share (subject to refund) together with

The Company will not issue temporary documents of title.

1% brokerage fee, 0.0027% SFC transaction levy

Share certificates will only become valid at 8:00 a.m. on

and 0.005% Stock Exchange trading fee. If the Offer

Wednesday, 25 September 2019 provided that the Global

Price is not agreed among the Company and the Joint

Offering has become unconditional in all respects and the

Representatives (on behalf of the Underwriters) on or

right of termination under the Underwriting Agreements

before Tuesday, 24 September 2019, the Global Offering

and described in the section headed "Underwriting" in

will not proceed and will lapse.

the Prospectus has not been exercised. No receipt will be

Allotment of Reserved Shares

issued for sums paid on application. In the event that the

Subject to the terms and conditions as set out herein and in

Offer Price is less than the price per Reserved Share paid

the Prospectus, the Reserved Shares will be allotted after the

by you, the surplus application money (including the

application lists close.

brokerage fee, the SFC transaction levy and the Stock

The Company expects to announce the Offer Price, the level

Exchange trading fee attributable to such surplus) will

of indications of interest in the International Offering, the

be refunded to you without interest. Investors who trade

level of applications under the Hong Kong Public Offering

Shares prior to the receipt of Share certificates or prior

and the Preferential Offering, and the basis of allocation of

to the Share certificates becoming valid do so entirely at

the Hong Kong Offer Shares and the Reserved Shares on

their own risk.

Tuesday, 24 September 2019 in South China Morning Post

Circumstances in which you will not be allotted Reserved

(in English), Hong Kong Economic Times (in Chin s ),

Shar s

the website of the Stock Exchange at www.hkexn ws.hk

You may not be allocated Reserved Shares for any of the

and the Company's website www.henlius.com. R su ts of

fo owing r asons:

allocations and the Hong Kong Identity Card/passport/Hong

1. If your application is revoked:

Kong business registration numbers of successful app icants

By compl ting and submitting an Application Form or

under the Hong Kong Public Offering and the Pr f r ntial

givingl ctronic application instructions to HKSCC or

Offering will be available on the above websites.

through the Orange Form eIPO service, you agree that

If your application for Reserved Shares is successful (in

your application or the application made by HKSCC

whole or in part)

Nominees on your behalf cannot be revoked on or before

If you apply for 1,000,000 or more Reserved Shares and have

the expiration of the fifth day after the time of the opening

provided all information required by this A lication Form, you

of the application lists (excluding for this purpose any day

may collect your refund cheque(s) and/or share certificate(s)

which is not a business day), unless a person responsible

from Computershare Hong Kong Investor Services Li ited, at

for the Prospectus under Section 40 of the Companies

Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's

(Winding Up and Miscellaneous Provisions) Ordinance

Road East, W nch i, Hong Kong, from 9:00 a. . to 1:00 p.m.

(Chapter 32 of the Laws of Hong Kong) gives a public

on Tuesd y, 24 Septe ber 2019 or such other place or date as

notice under that section which excludes or limits the

notified by us in the newsp pers.

responsibility of that person for the Prospectus. This

If you are n individu l who is eligible for personal collection,

agreement will take effect as a collateral contract with

you must not uthorise ny other person to collect for you. If

the Company, and will become binding when you lodge

you are a corporate applicant which is eligible for personal

this Application Form. This collateral contract will be

collection, your authorised representative must provide a letter

in consideration of the Company agreeing that they will

of authorisation from your corporation stamped with your

not offer any Reserved Shares to any person on or before

'

Tuesday, 24 September 2019, except by means of one of

corporation s chop.

Both individuals and authorised representatives must

the procedures referred to in the Prospectus.

produce, at the time of collection, evidence of identity

SampleIf your application has been accepted, it cannot be

acceptable to Computershare Hong Kong Investor Services

revoked. For this purpose, acceptance of applications

Limited.

which are not rejected will be constituted by notification

If you do not collect your refund cheque(s) and/or share

in the announcement of the results of allocation, and

certificate(s) personally within the time period specified for

where such basis of allocation is subject to certain

collection, they will be despatched promptly to the address

conditions

or provides for

allocation by ballot,

such

as specified on this Application Form by ordinary post at

acceptance

will be subject

to the satisfaction of

such

your own risk.

conditions or results of the ballot, respectively.

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

2. Full discretion of the Company, the Joint

alteration(s) to the application details on this

Representatives, and their respective agents or

Application Form has not been authorised by the

nominees, to reject or accept your application:

signature(s) of the applicant(s);

The Company and the Joint Representatives or its or

the Company believe that by accepting the application,

their respective agents or nominees, have full discretion

the Company would violate the applicable securities or

to reject or accept any application, or to accept only part

other laws, rules or regulations of the jurisdiction where

of any application. No reasons have to be given for any

this Application Form is received or where the applicant is

rejection or acceptance.

resident; or

3. If the allotment of Reserved Shares is void:

the Company and the Joint Representatives, and

The allotment of Reserved Shares to you will be void if

their respective agents or nominees, exercise their

the Listing Committee does not grant permission to list

discretion to reject or accept any application, or to

the Shares either:

accept only part of any application. No reasons have

within three weeks from the closing of the application

to be given for any rejection or acceptance.

lists; or

5. If you are applying by using the ORANGE Application

within a longer period of up to six weeks if the Listing

Committee of the Stock Exchange notifies the Company

Form for Assured Entitlement, you may apply for a number

of Reserved Shares pursuant to your Assured Entitlement

of that longer period within three weeks of the closing

that is equal to or less than the number stated in Box B. If

date of the application lists.

you intend to apply for a number of Reserved Shares that is

4. You will not receive any allotment if:

this Application Form is not completed in accordance

less than your Assured Entitlement, you MUST apply for a

with the instructions as stated herein;

number which is one of the numbers set out in the table in

Samplecomplete and sign the ORANGE Application Form for

this Application Form has not been duly signed (only

the ORANGE Application Form and make a payment of

written signatures are acceptable) (or in the case of a

the corr sponding amount (other than HKSCC Nominees).

joint application, not all applicants have signed);

You n

d to complete and sign the ORANGE

in respect of applicants who are corporate entiti s, this

Application Form for Assured Entitlement and

Application Form has not been duly signed (on y writt n

submit one cheque (or banker's cashier order) for the

signature is acceptable) by an authorised offic r or

xact amount

of remittance printed in Box B or the

affixed with a company chop;

corr sponding amount payable as set out in the table in

the cheque/banker's cashier order/this A

ication

the ORANGE Application Form. If you intend to apply

Form is defective;

for a number of Assured Entitlement which is not one

this Application Form is not accom anied with a

of the

numbers set out in the table in the ORANGE

cheque/banker's cashier order or is accom

anied by

Application Form for Assured Entitlement, you MUST

more than one cheque/banker's cashier order for each

apply by using Orange Form eIPO only. If you wish

of the application for Assured Entitle ent and excess

to apply for excess Reserved Shares in addition to your

application for Reserved Shares;

Assured Entitlement, you should complete and sign the

the account na

e on cheque/banker's cashier order is

ORANGE Application Form for excess Reserved Shares

not pre-printed or certified by the issuing bank;

and lodge it,

together with a separate remittance for

the cheque/b nker's c shier order is not drawn on a

the full amount payable on application in respect of the

Hong Kong doll r b nk

ccount in Hong Kong;

excess Reserved Shares applied for or apply for through

the n me of

the p yee indicated on the

cheque/

b nker's c shier order is not "BANK OF CHINA

the Orange Form eIPO service via www.eipo.com.hk.

(HONG KONG) NOMINEES LIMITED -

6. If you are applying by using the ORANGE Application

HENLIUS BIOTECH PREFERENTIAL

Form for excess Reserved Shares, you MUST apply for

OFFER";

a number which is one of the numbers set out in the table

the cheque has not been crossed "Account payee

in the ORANGE Application Form for excess Reserved

only";

Shares

and make a payment of the corresponding

the cheque was post-dated;

amount (other than HKSCC Nominees). You need to

the applicant's payment is not made correctly or

the applicant

pays by

cheque or

banker's cashier

excess Reserved Shares and submit a separate cheque

order and the

cheque

or banker's

cashier

order

is

(or banker's

cashier order) for the exact amount of

dishonoured on its first presentation;

remittance. If you intend to apply for a number of excess

the applicant's name/the first applicant's

name

on

the joint application is not the same as the name pre-

Reserved Shares which is not one of the numbers set

out in the table in the ORANGE Application Form for

printed or certified/endorsed by a person authorised

by the drawee bank on the cheque/banker's cashier

excess Reserved Shares, you MUST apply by using

order;

Orange Form eIPO only.

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

7. If you intend to apply for both Reserved Shares pursuant

1. Reasons for the collection of your personal data

to your Assured Entitlement and excess Reserved Shares,

From time to time it is necessary for applicants for

you must submit both the ORANGE Application Form

securities or registered holders of securities to supply

for Assured Entitlement and the ORANGE Application

their latest correct personal data to the Company and

Form for excess Reserved Shares. Each ORANGE

its H Share Registrar when applying for securities or

Application Form must be accompanied by a separate

transferring securities into or out of their names or in

cheque (or banker's cashier order) for the exact amount

procuring the services of the H Share Registrar. Failure to

of remittance.

supply the requested data may result in your application

Refund of your money

for securities being rejected or in delay or inability of

the Company or its H Share Registrar to effect transfers

If you do not receive any Reserved Shares or if your

or otherwise render their services. It may also prevent

application is accepted only in part, the Company will

or delay registration or transfer of the Reserved Shares

refund to you your application monies (including the

which you have successfully applied for and/or the

related 1% brokerage fee, 0.0027% SFC transaction levy

despatch of Share certificate(s), and/or the despatch of

and 0.005% Stock Exchange trading fee) or the appropriate

refund cheque(s) to which you are entitled.

portion thereof

without interest. If

the Offer Price is less

It is important

that holders of securities

inform

the

than the Maximum Offer Price, the Company will refund to

Company and the H Share Registrar immediately of any

you the surplus application monies (including the related 1%

inaccuracies in the personal data supplied.

brokerage fee, 0.0027% SFC transaction levy and 0.005%

2. Purposes

Stock Exchange trading fee) without interest. The refund

procedures are stated in the

"H.

Despatch/Collection

of

The personal data of the applicants and the holders of

Sample

Share Certificates/e-Refund

Payment Institutions/Refund

securities may be used, held and/or stored (by whatever

Cheques" in the "How to Apply for Hong Kong Off r

m ans) for the following purposes:

Shares and Reserved Shares" section of the Prospectus.

proc ssing

of your application and

refund cheque,

Effect of the Information You Give to Comput rshare

wh re applicable, and verification of compliance with

the t rms and application procedures set out in this

Hong Kong Investor Services Limited

Application Form and the Prospectus and announcing

Computershare Hong Kong Investor Services Limit d and

r sults of allocations of the Reserved Shares;

its related bodies' corporate, directors, officers, em oy

s

nabling compliance with all applicable laws and

and agents ("Representatives") ex ressly disc aim and

regulations in Hong Kong and elsewhere;

exclude to

the

maximum extent

ermitted by

aw any

registering new issues or transfers into or out

of

liability for any loss or damage suffered or incurred by the

the name of holders of securities including, where

applicant or any other person or entity however caused

applicable, in the name of HKSCC Nominees;

relating in any way to, or connected with, any information

maintaining or updating the registers of holders of

provided by or on behalf of the applicant on or in connection

securities of the Company;

with this document or any services provided hereunder, or

conducting

or assisting

in the conduct

of signature

any other written or oral co

unication provided by or on

verifications,

any other

verification

or

exchange

of

information;

behalf of the

pplic nt in connection with this document

establishing

benefit

entitlements

of

holders

of

or any services provided hereunder. This includes, without

securities of the Company, such as dividends, rights

limitation,

ny

errors or o

issions in such information

issues and bonus issues, etc.;

however c used, or the Represent tives or any other person

distributing communications from the Company and

or entity pl cing ny reli nce on such information or any

its subsidiaries;

document tion,

im ge, recording or reproduction

of such

compiling

statistical

information

and

profiles

of

information,

or

its accuracy, completeness, currency

or

holders of securities;

reliability.

making disclosures as required by laws, rules or

Personal Data

regulations (whether statutory or otherwise) in Hong

Personal information collection statement

Kong or elsewhere;

disclosing relevant information to facilitate claims on

The main provisions of the Personal Data (Privacy)

Ordinance (Chapter 486 of the Laws of Hong Kong) (the

entitlements; and

"Ordinance") came into effect in Hong Kong on December

any other incidental or

associated purposes relating

to the above and/or to enable the Company and the

20, 1996. This Personal Information Collection Statement

H Share Registrar to

discharge their obligations

to

informs the applicant for and holder of the Hong Kong

holders of

securities

and/or regulators

and/or other

Offer Shares of the policies and practices of the Company

and its H Share Registrar in relation to personal data and the

purpose to which the holders of securities may from

time to time agree.

Ordinance.

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

3. Transfer of personal data

By signing this Application Form, you agree to all of the

Personal data held by the Company and the H Share

above.

Registrar

relating

to the

applicants

and

the

holders of

How to make your application

securities

will be

kept

confidential

but

the

Company

Instead of using the ORANGE Application Form, you

and the H Share Registrar, to the extent necessary for

may apply for Reserved Shares through the Orange

achieving the above purposes or any of them, may make

Form eIPO service at www.eipo.com.hkand make

such enquiries as they consider necessary to confirm the

payment using PPS or the internet banking payment

accuracy of the personal data and in particular, they may

methods.

disclose, obtain or transfer (whether within or outside

1. If you are applying by using the ORANGE

Hong Kong) the personal data of the applicants and the

Application Form for Assured Entitlement, you may

holders of securities to, from or with any and all of the

apply for a number of Reserved Shares pursuant to your

following persons and entities:

Assured Entitlement that is equal to or less than the

the Company or their respective appointed agents

number stated in Box B in the Application Form. If you

such as financial advisors and receiving bankers;

intend to apply for a number of Reserved Shares that is

HKSCC and HKSCC Nominees, who will use the

less than your Assured Entitlement, you MUST apply

personal data for the purposes of operating CCASS

for a number which is one of the numbers set out in the

(in cases where the applicants have requested for the

table in the ORANGE Application Form for Assured

Entitlement, you should (i) write the number of Reserved

Reserved Shares to be deposited into CCASS);

Shares applied for and the amount payable (as set out

any agents, contractors or third-party service providers who

offer administrative,

telecommunications,

computer,

in the table in the Application Form); (ii) complete and

sign the Application Form; and (iii) submit one cheque

Sample

payment or other services to the Company and/or the

H Share Registrar in connection with the operation of

(or banker's cashier order) for the same amount that

their respective businesses;

you have written in the Application Form (other than

the Stock Exchange, the SFC and any other statutory,

HKSCC Nominees). If you intend to apply for a number

regulatory or governmental bodies in Hong Kong or

of Assur d Entitlement which is not one of the numbers

elsewhere; and

s t out in the table in the ORANGE Application Form

any other persons or institutions with

which the

for Assur d Entitlement, you MUST apply by using

Orange Form eIPO only. If you wish to apply for excess

holders of securities have or ro ose to have d a ings,

such as their bankers, solicitors, accountants or

R s rv d Shares in addition to your Assured Entitlement,

you should complete and sign the ORANGE Application

stockbrokers.

Form for excess Reserved Shares and lodge it, together

4. Retention of personal data

with a separate remittance for the full amount payable

The Company and its H Share Registrar will keep the

on application in respect of the excess Reserved Shares

personal data of the applicants and holders of securities

applied for or apply for through the Orange Form eIPO

for as long as necessary to fulfil the purposes for which

service via

www.eipo.com.hk. If you intend to apply

the personal

data

were

collected. Personal data which

for a number of Reserved Shares that is equal to your

Assured Entitlement, you should (i) complete and sign the

is no longer required will be destroyed or dealt with in

Application Form and (ii) submit one cheque (or banker's

accord nce with the Ordin nce.

cashier order) for the exact amount of remittance printed

5. Access to

nd correction of personal data

in Box B in the Application Form.

The Ordin nce provides the pplicants and the holders of

If you are applying by using the ORANGE Application

Form for excess Reserved Shares, you should (i) write

securities with rights to

scert in whether the Company

the number of excess Reserved Shares applied for and the

or the H

h re Registr r holds their personal

data, to

amount payable (as set out in the table on the Application

obtain a copy of that data, and to correct any data that

Form); (ii) complete and sign the Application Form; and

is inaccurate. In

accordance with the Ordinance, the

(iii) submit

one separate cheque (or banker's cashier

Company and the H Share Registrar have the right

order) for the same amount that you have written on the

to charge

a

reasonable

fee for the

processing

of any

Application Form. The number of excess Reserved Shares

data access

request. All

requests for access

to

data or

that you intend to apply for MUST be one of the numbers

correction of data or for information regarding policies

set out in the table in the Application Form for excess

and practices and kinds of data held should be addressed

Reserved Shares (other than HKSCC Nominees). If you

to the Company,

at its registered

address

disclosed

intend to apply for a number of excess Reserved Shares

in the section headed "Corporate Information" in the

which is not one of the numbers set out in the table in the

Prospectus or as notified from time to time in accordance

ORANGE Application Form for excess Reserved Shares,

with applicable law, for the attention of the company

you MUST apply by using Orange Form eIPO only.

secretary, or the H Share Registrar for the attention of the

2. Complete the form and sign it. Only written signatures

privacy compliance officer.

will be accepted.

ORANGE FORM

Please use this Application Form if you are a Qualifying Fosun International Shareholder and have difficulties applying online via www.eipo.com.hk

'

Kowloon

Telford Plaza Branch

Shop Unit P2-P7, Telford Plaza,

3. Staple your cheque or bank s cashier order to the form.

You must pay for the application for Assured Entitlement

No.33 Wai Yip Street, Kowloon

by one cheque or by one banker's cashier order and/

Bay, Kowloon

or pay

for

the application

for excess

Reserved Shares

Olympian City Branch

Shop 133, 1/F, Olympian City 2, 18

by one cheque or by one banker's cashier order. Each

Hoi Ting Road, Kowloon

application

must be accompanied by

either a separate

New Territories

Metro City Branch

Shop 209, Level 2, Metro City

cheque or banker's cashier order.

Phase 1, Tseung Kwan O, New

If you pay by cheque, the cheque must:

Territories

be in Hong Kong dollars;

be drawn on your Hong Kong dollar bank account in

Ma On Shan Plaza Branch

Shop 2103, Level 2, Ma On Shan

Hong Kong;

Plaza, Sai Sha Road, Ma On Shan,

show your account name. This name must either be

New Territories

preprinted on the cheque, or be endorsed at the back

CMB Wing Lung Bank Limited

by a person authorised by the bank. This account

District

Branch Name

Address

name must be the same name as the name on this

Hong Kong Island

Head Office

45 Des Voeux Road Central

form. If it is a joint application, the account name

must be the same as the name of the first-named

Kennedy Town Branch

28 Catchick Street

applicant;

Kowloon

Mongkok Branch

B/F CMB Wing Lung Bank Centre,

be made payable to "BANK OF CHINA (HONG

636 Nathan Road

KONG) NOMINEES LIMITED - HENLIUS

Tsim Sha Tsui Branch

4 Carnarvon Road

BIOTECH PREFERENTIAL OFFER";

be crossed "Account Payee Only"; and

New Territories

Tsuen Wan Branch

251 Sha Tsui Road

not be post-dated.

5. This Application Form can be lodged at these times:

Your application may be rejected if your chequ :

does not meet all these requirements; or

Thursday, 12 September 2019

-

9:00 a.m. to 5:00 p.m.

is dishonoured on its first presentation.

Friday, 13 September 2019

-

9:00 a.m. to 5:00 p.m.

If you pay by banker's cashier order, the cashi r

Monday, 16 September 2019

-

9:00 a.m. to 5:00 p.m.

order must:

be in Hong Kong dollars;

Tu sday, 17 September 2019 -

9:00 a.m. to 12:00 noon

be issued by licensed banks in Hong Kong, and have

6. The latest time for lodging your application is 12:00 noon

your name certified at

the back of

the order by a

on Tuesday, 17 September 2019 or, if the application lists

person authorised by the bank. The name on the back

are not open on that day, then by 12:00 noon on the next

of the order and the name on this A

lication Form

day the lists are open. The application lists will be open

must be the same. If it is a joint a

lication, the name

between 11:45 a.m. and 12:00 noon on that day, subject

at the back of the order

ust be the sa

e as the name

only to weather conditions. The application lists will not

of the first-na ed applicant;

open if there is:

be made payable to "BANK OF CHINA (HONG

a typhoon warning signal 8 or above;

KONG) NOMINEES LIMITED - HENLIUS

an extreme condition caused by a super typhoon

announced by the Government of the Hong Kong

BIOTECH PREFERENTIAL OFFER";

Special Administrative Region; or

be crossed "Account P yee Only"; and

a "black" rainstorm warning

not be post-d ted.

in force in Hong Kong at any time between 9:00 a.m.

Your

pplic tion is li ble to be rejected if your cheque

and 12:00 noon on Tuesday, 17 September 2019. Instead

or b nker's c shier order does not meet all these

they will be open between 11:45 a.m. and 12:00 noon on

requirements.

the next business day which does not have either of those

4. Fold this Application Form once and lodge it to one of

warnings and/or extreme condition in force at any time

between 9:00 a.m. and 12:00 noon. Business day means

the collection boxes at any of the following branches of

a day that is not a Saturday, Sunday or public holiday in

Bank of China (Hong Kong) Limited and CMB Wing

Hong Kong.

Lung Bank Limited:

7. The right is reserved to present all or any remittances

Sample

Bank of China (Hong Kong) Limited

for payment. However, your cheque or banker's

District

Branch Name

Address

cashier order will not be presented for payment

Hong Kong Island

Des Voeux Road

111-119 Des Voeux Road West,

before 12:00 noon on Tuesday, 17 September

September 2019. You will not be given a receipt for

West Branch

Hong Kong

your payment. The Company will retain any interest

Chai Wan Branch

Block B, Walton Estate, 341-343

accrued on your application monies. The right is also

reserved to retain any Share certificate(s) and/or any

Chai Wan Road, Chai Wan, Hong

surplus application money(ies) or refunds pending

Kong

clearance of your cheque or banker's cashier order.

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

Shanghai Henlius Biotech, Inc.

上 海 復 宏 漢 霖 生 物 技 術 股 份 有 限 公 司

(於中華人民共和國註冊成立的股份有限公司)

全 球 發 售

申請條件

不管招股章程或本申請表格的任何其他

除另有指明外,此等條件所用詞彙具備招股章程

條文或橙表eIPO 服務的條款及條件,倘

所賦予的相同涵義。

本公司全權酌情信納有關交易獲豁免或

. 申請人資格

毋須遵守導致上述限制的法例或規例,

1.

閣下(申請人)及 閣下為其利益而提出

則本公司保留權利允許任何復星國際股

申請的任何人士必須為合資格復星國際

股東及年滿18 歲。

東接納其預留股份的保證配額。

2.

如 閣下屬商號,則須以個別成員的名

5.

聯名申請人的總數不可超過四人。

義而非以商號的名義作出申請。

.

分配預留股份

3.

如 閣下屬法人團體,申請表格必須加

倘有效申請之預留股份數目少於或相等

蓋公司印鑑(附有公司名稱)並由獲正式

閣下之保證配額,在受本申請表格所

載條款及條件的規限下,且假設優先發售

授權的高級職員簽署,並須註明其代表

之條件已達成,則申請將會獲全數接納。

身份。

倘申請的預留股份數目少於 閣下的保證配

4.

除上市規則及聯交所發出的指引信許可

額, 閣下必須申請本申請表格內數目及款

的情況或聯交所已授予的任何相關豁免

項一覽表所列的其中一個數目並支付相應款

批准外,倘若 閣下或(香港結算代理人

額(香港結算代理人除外)。倘 閣下擬申請

除外) 閣下為其利益而提出申請的任何

人士為下列人士,則不得申請認購任何

並非橙色申請表格申請保證配額表中載列的

預留股份:

其中一個保證配額數目, 閣下必須橙表

本公司及或任何附屬公司之股份

eIPO 申請。倘

閣下擬申請保證配額以外的

的現有實益擁有人;

超額預留股份,則須填妥並簽署申請超額預

本公司及或本公司任何附屬公司

留股份之橙色申請表格,並單獨匯款足額支

之董事或最高行政人員;

付所申請超額預留股份的應付股款,或透過

上述任何人士的聯繫人;

www.eipo.com.hk使用橙表eIPO 服務遞交

本公司的關連人士或於緊隨全球發

申請。倘申請的預留股份數目多於 閣下的

售完成後將成為本公司關連人士的

保證配額,相關保證配額的申請將獲全數接

人士;或

納,但超額預留股份的申請則只在有足夠的

不合資格復星國際股東。

可用預留股份的情況下方獲接納。倘預留股

不合資格復星國際股東指於記錄日期登

份的超額申請:

記地址位於香港以外司法權區或據復星

(i)

少於可用預留股份,則可用預留股份將

國際另行得悉為香港以外司法權區居民

Sample的復星國際股東,復星國際及本公司董

首先悉數分配以滿足該等預留股份的超

事根據彼等就該等股東所作出的查詢,

額申請,而其後將由聯席代表酌情分配

至國際發售;

考慮到有關復星國際股東所處有關司法

(ii) 與可用預留股份相同,則可用預留股份

權區法律的限制或該司法權區有關監管

將悉數分配以滿足該等預留股份的超額

機構或證券交易所的規定後,認為將彼

申請;或

等排除在優先發售之外屬必要或合宜者。

(iii) 多於可用預留股份,則可用預留股份將

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

按與香港公開發售超額認購情況下常用

指示授權本公司及或聯席代表(或

的分配基準一致的分配基準分配,當中

彼等各自的代理或代名人),根據本公

認購額較細的申請將獲較高的分配百分

司章程細則的規定,代表 閣下簽立任

比。倘滿足超額申請後有任何剩餘的股

何過戶表格、成交單據或其他文件,並

份,有關股份將由聯席代表酌情重新分

代表

閣下辦理其他一切必需手續,以

配至國際發售。為補足股份的零碎持有

完成以 閣下名義登記 閣下獲分配的

量至一手完整持有量而作出的任何超額

任何預留股份,或以其他方式令招股章

申請將不會獲得優先處理。

程及本申請表格所述的各項安排落實生

除上述者外,優先發售將不受國際發售與香

效;

港公開發售之間的回補安排所限。未附帶正

承諾簽署所有文件及辦理所有必需手

確金額申請款項的任何申請將視為完全無效

續,以便可按本公司章程細則的規定,

且不會向有關申請人配發任何預留股份。

閣下登記成為

閣下獲分配的預留

除透過橙表eIPO 服務(www.eipo.com.hk)

橙色申請表格申請預留股份外,合資格復

股份的持有人;

星國際股東亦可使用白色黃色申請表格或

聲明保證承諾

閣下明白預留股份

透過中央結算系統向香港結算發出電子認購

並無亦不會根據《美國證券法》進行登

指示或透過白表eIPO 服務作出一份香港發

記,而(香港結算代理人除外) 閣下

售股份申請。

閣下作為其代表或為其利益購買預

Sample

留股份的任何其他人士身處美國境外(定

合資格復星國際股東根據香港公開發售使用

義見S 規例)及S 規例第902 條第(h)(3)

白色黃色申請表格或向香港結算發出電子

所述的人士;

認購指示或透過白表eIPO 服務申請香港發

確認

閣下提出本申請時僅依賴招股章

售股份,在配額或分配方面並無優先權。

程所載的資料及陳述,而除招股章程任

合資格復星國際股東可按其各自於記錄日期

何補充文件所載者外,將不會依賴任何

每持有2,041 股復星國際股份的完整倍數獲

其他資料或陳述;

發保證配額一個預留股份的基準提出申請。

同意本公司、有關人士或橙表及藍表

於記錄日期持有少於2,041 股復星國際股份

eIPO 服務供應商現時及日後均毋須對並

的合資格復星國際股東將不會享有預留股份

非載於招股章程(及其任何補充文件)的

的保證配額,但仍有權透過申請超額預留股

任何資料及陳述負責;

份參與優先發售。

同意(在不損害 閣下可能擁有的任何其

. 補充資料

他權利的情況下)本申請一經接納,即不

倘刊發招股章程的任何補充文件,已提交

得因無意的失實陳述而撤銷;

申請的申請人可能會或可能不會(視乎補充

(如 申 請 由 代 理 代 表 閣 下 提 出 )

文件所載資料而定)獲通知彼等須確認其申

閣下已向

閣下的代理有效及不可

請。如申請人已獲通知但未有根據獲通知的

撤回地授予一切必需的權力及授權以提

程序確認彼等的申請,則所有未經確認申請

將會無效。受上文所規限,申請一經提交即

出本申請;

不得撤銷,而申請人將視為根據已按經補充

(如

閣下為他人的代理)保證已向實益

的招股章程提出申請。

擁有人作出合理查詢,證實本申請乃為

. 填交本申請表格的效用

該人士利益以橙色申請表格而作出的唯

一申請,而 閣下已獲正式授權,以該

本申請表格一經填妥及提交,即表明 閣下

(及如屬聯名申請人,即 閣下與聯名申請

人士代理的身份簽署本申請表格;

人共同及個別)本身或(如作為代理人或代名

同意

閣下的申請一經接納, 閣下的申

人)代表委託 閣下作為代理人或代名人的

請將以本公司公佈的優先發售結果為證

每名人士:

明;

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

保證本申請所載資料屬真實及準確;

確認 閣下知悉招股章程所述有關預留

同意向本公司、H 股證券登記處、收款

股份的優先發售限制;

銀行、有關人士及橙表及藍表eIPO 服務

明白本公司及聯席代表將依賴此等聲明

供應商披露彼等所需關於 閣下或(香港

及陳述,以決定是否就 閣下提出的申

結算代理人除外) 閣下為其利益提出申

請向 閣下分配任何預留股份;

請的人士的任何個人資料;

倘香港境外任何地方的法律適用於 閣

保證在提出申請時, 閣下或

閣下可能

下的申請,則 閣下同意保證, 閣下

代其行事之任何人士為合資格復星國際

已遵守所有該等法律,而本公司或有關

股東;

人士概不會因接納

閣下購買任何預留

聲 明 保 證 承 諾, 在 提 出 本 申 請

股份的要約,或因

閣下在招股章程所

時, 閣下及或(香港結算代理人除

載條款及條件項下的權利與責任所產生

外) 閣下可能代其行事之任何人士並

的任何行動而觸犯香港境外任何法律;

非關連人士,亦並非將在緊隨全球發售

向本公司(並為各股東的利益)表示同意

完成後成為本公司關連人士的人士,

(及從而使本公司(為其本身並代表各股

東)藉其接納全部或部分本申請而視為已

而 閣 下 及 或(香 港 結 算 代 理 人 除

同意)(及(如適用)向發出電子認購指示

外) 閣下可能代其行事之任何人士認購

的各中央結算系統參與者表示同意),以

預留股份並非直接或間接由本公司的關

Sample

及本公司向各股東表示同意,遵守及符

連人士提供資金,且 閣下及或(香港

合香港法例第622 章公司條例、香港法

結算代理人除外) 閣下可能代其行事之

例第32 章公司(清盤及雜項條文)條例及

任何人士並非根據本公司關連人士的指

本公司章程細則;

示作出預留股份的是次認購;

向本公司及各股東表示同意股份可由該

同意 閣下的申請、接納申請及由此而

股東自由轉讓;及

產生的合約均受香港法例管轄,並按其

明白本公司及有關人士均有權依賴 閣

詮釋;

下於本申請作出的任何保證、陳述或聲

承諾同意接納所申請的預留股份,

明。倘為聯名申請人提出的申請,表示

或 閣下根據申請所獲分配的任何較少

由聯名申請人提出、作出或承擔或須履

數目;

行的所有保證、陳述、聲明及責任,均

授權本公司將 閣下的姓名名稱列

視為由各申請人共同及個別地提出、作

H 股股份登記冊,作為 閣下獲分配

出及承擔及須履行。

閣下如作出虛假

的任何預留股份的持有人,及根據本公

聲明可被檢控。

司章程細則規定的本公司股東名冊內,

除另有註明外, 閣下必須以英文填妥本申

並按本申請表格上所示地址以普通郵遞

請,而 閣下或(倘為聯名申請人)各聯名申

方式寄發任何股票(如適用)及或任何

請人必須親筆簽署本申請(不得以個人印章

退款支票(如適用予 閣下或(如為聯名

代替),否則申請可被拒絕受理。

申請人)本申請表格內排名首位的申請

. 授權書

人,郵誤風險概由 閣下自行承擔(除非

閣下的申請由根據授權書獲正式授權的

如 閣下申請1,000,000 股或以上預留股

人士提出,本公司及聯席代表(作為本公司的

份,則可親自領取 閣下的退款支票及

代理)可酌情按彼等認為合適的任何條件(包

股票(如適用));

括出示代表的授權證明文件)接納申請。本

同意任何收款銀行,而不限於

閣下遞

公司及聯席代表(作為本公司的代理)將可全

交申請表格的銀行,可處理

閣下的申

權酌情決定拒絕或接納任何申請的全部或部

請,包括寄發退款支票(如有); 分,而毋須提供任何理由。

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

. 釐定發售價

年九月二十四日(星期二)或之前以普通郵遞方式

預期發售價於二零一九年九月十七日(星期二)或

寄往

閣下申請表格所示地址,郵誤風險由 閣

前後釐定。申請人須繳付每股發售股份57.80

下承擔。

元(多繳款項可予退還)的最高發售價,另加1%

本公司不會發出臨時所有權文件。

經紀佣金、0.0027% 證監會交易徵費及0.005%

股票僅會於全球發售在所有方面成為無條件及招

交所交易費。倘若本公司與聯席代表(代表包銷

股章程「包銷」一節所述的包銷協議終止權利並無

商)並無於二零一九年九月二十四日(星期二)或

行使的情況下,方會於二零一九年九月二十五日

之前協定發售價,全球發售將不會進行並將告失

(星期三)上午八時正成為有效的所有權憑證。

效。

已繳付的申請款項將不獲發收據。倘發售價低

預留股份的配發

閣下支付的每股預留股份價格,多繳的申請

款項(包括多繳款項應佔的經紀佣金、證監會交

在本申請表格及招股章程載列的條款及條件規限

易徵費及聯交所交易費)將不計利息退還予 閣

下,預留股份將於截止辦理申請登記後配發。

下。投資者在收到股票前或在股票成為有效前買

本公司預期於二零一九年九月二十四日(星期二)

賣股份,須自行承擔全部風險。

在《南華早報》(英文)、《香港經濟日報》(中文)、

聯交所網站(www.hkexnews.hk) 及本公司網站

閣下不獲配發預留股份的情況

(www.henlius.com) 公佈發售價、國際發售的踴

閣下可能基於下列任何理由而不獲分配預留股

躍程度、香港公開發售及優先發售的認購水平以

份:

及香港發售股份及預留股份的分配基準。香港公

1. 倘 閣下的申請被撤回:

開發售及優先發售的分配結果及成功申請人的香

填妥及遞交申請表格或向香港結算或利用橙表

港身份證護照香港商業登記號碼亦同於上述

IPO 服務發出電子認購指示後,即表示 閣下

網站公佈。

同意不得於開始辦理申請登記後第五日(就此而

閣下成功申請認購(全部或部分)預留股份

言,不包括任何非營業日)屆滿或之前撤回申請

或香港結算代理人代表 閣下提出的申請,除非

閣下申請認購1,000,000 股或以上預留股

根據香港法例第32 章公司(清盤及雜項條文)條

份,且已提供本申請表格所規定全部資料, 閣

例第40 條對招股章程負責的人士根據該條發出公

下可於二零一九年九月二十四日(星期二)或本公

告,免除或限制該人士對招股章程的責任。此協

司在報章上公佈的其他地點或日期的上午九時正

議將成為本公司訂立的附屬合約,並在 閣下遞

至下午一時正,親身前往香港中央證券登記有限

交本申請表格時即具約束力。該附屬合約的代價

公司(地址為香港灣仔皇后大道東183 號合和中

為本公司同意,除按招股章程所述任何一項程序

171712-1716 室)領取 閣下的退款支票及

外,不會於二零一九年九月二十四日(星期二)或

或股票。

之前向任何人士提呈發售任何預留股份。

閣下為個人申請人並合資格親身領取, 閣

閣下的申請一經接納,則不得撤回。就此而言,

下不得授權任何其他人士代領。如 閣下為公司

在公告公佈分配結果即屬接納未遭拒絕的申請,

申請人並合資格親身領取, 閣下的授權代表須

而倘有關分配基準受若干條件規限或訂定以抽籤

攜同蓋上公司印鑑的授權書領取。

方式分配,則申請獲接納與否將分別視乎能否達

個人申請人及授權代表領取時均須出示香港中央

成有關條件或抽籤的結果而定。

證券登記有限公司接納的身份證明文件。

2. 本公司、聯席代表以及彼等各自的代理或代

閣下並無在指定領取時間內親身領取退款支

名人可全權酌情決定拒絕或接納 閣下的申

Sample

票及或股票,有關退款支票及或股票將會立

請:

刻以普通郵遞方式寄往本申請表格所示地址,郵

本公司及聯席代表或彼等各自的代理或代名

誤風險由 閣下承擔。

人可全權酌情決定拒絕或接納任何申請,或

閣 下 申 請 認 購1,000,000 股 以 下 預 留 股

僅接納任何部份申請,而毋須就任何拒絕或

份, 閣下的退款支票及或股票將於二零一九

接納提供任何理由。

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

3.

倘預留股份配發作廢:

本公司及聯席代表及其各自的代理或代

倘上市委員會在下列期間未批准股份上市,

名人行使酌情權,決定拒絕或接納任何

則配發予 閣下的預留股份將告作廢:

申請,或僅接納部分申請。拒絕或接納

由截止辦理申請登記日期起計三星期

申請毋須給予任何理由。

內;或

5. 倘 閣下使用橙色申請表格申請保證配

(倘聯交所上市委員會在截止辦理申請登

額, 閣下可申請相等於或少於乙欄所列數目

記日期後三星期內通知本公司延長有關

的保證配額的預留股份。倘 閣下擬申請少

期間)由截止辦理申請登記日期起計最多

於 閣下保證配額的預留股份, 閣下必須

六星期內。

橙色申請表格一覽表所列數目之一,並相

4.

在下列情況下, 閣下將不獲任何配發:

應付款(香港結算代理人除外)。

本申請表格並無按照本申請表格所載指

閣下須就保證配額填妥並簽署橙色申請表

示填妥;

格,並提交一張支票(或銀行本票),金額須

本申請表格並無妥為簽署(僅接受親筆簽

為乙欄所印列的確切金額或橙色申請表格一

名)(倘為聯名申請,則未經全部申請人

覽表所載的相應應付金額。倘 閣下擬申請

簽署);

並非橙色申請表格申請保證配額表中載列的

就法人團體申請人而言,本申請表格未

其中一個保證配額數目, 閣下必須使用橙表

經獲授權的高級職員妥為簽署(僅接受親

eIPO 申請。倘 閣下擬申請保證配額以外的

筆簽名)或未加蓋公司印鑑;

超額預留股份,則須填妥並簽署申請超額預

Sample同;

支票銀行本票本申請表格有缺陷;

留股份之橙色申請表格,並單獨匯款足額支

本申請表格並無就各份保證配額的申請

付所申請超額預留股份的應付股款,或透過

及預留股份的超額申請附有支票銀行

www. ipo.com.hk使用橙表eIPO 服務遞交申

本票或附有超過一張支票銀行本票;

請。

支票銀行本票並無預印賬戶名稱或賬

6. 倘 閣下使用橙色申請表格申請超額預留股

戶名稱未經開具銀行證明;

份, 閣下必須申請橙色申請表格一覽表所

支票銀行本票並非自香港的港元銀行

列超額預留股份數目之一,並相應付款(香

賬戶開出;

港結算代理人除外)。 閣下須就超額預留

支票銀行本票的抬頭人並非「中國銀行

股份填妥並簽署橙色申請表格,並提交一張

( 香港) 代理人有限公司-復宏漢霖生物

獨立開出的支票(或銀行本票)支付確切金

技術優先發售」;

額。倘 閣下擬申請並非橙色申請表格申請

支票並無劃線註明「只准存入抬頭人賬

超額預留股份表中載列的其中一個保證配額

戶」;

數目, 閣下必須使用橙表eIPO 申請。

支票為期票;

7. 倘 閣下擬同時申請保證配額的預留股份及

申請人未正確付款或申請人以支票或銀

超額預留股份, 閣下必須同時提交保證配

行本票付款但支票或銀行本票於首次過

額的橙色申請表格及超額預留股份的橙色

戶時不獲兌現;

請表格。每份橙色申請表格必須附上一張獨

申請人名稱聯名申請的排名首位申請

立開出的支票(或銀行本票)支付確切金額。

人名稱並非預印名稱或並非由銀行授權

退回款項

人士在支票或銀行本票背書的名稱相

若 閣下未獲分配任何預留股份或申請僅部分獲

本申請表格所提供申請資料的更改未獲

接納,本公司將不計利息退回 閣下的申請股款

申請人簽署授權;

(包括相關的1% 經紀佣金、0.0027% 證監會交易

本公司相信如接納申請,會違反收取本

徵費及0.005% 聯交所交易費)或其中適當部分。

申請表格或申請人地址所在司法權區的

如發售價低於最高發售價,本公司將不計利息

適用證券或其他法例、規則或規例;或

退回多收申請股款(包括相關的1% 經紀佣金、

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

0.0027% 證監會交易徵費及0.005% 聯交所交易

2.

目的

費)。有關退款程序載於招股章程「如何申請香港

證券申請人及持有人的個人資料可以作以下

發售股份及預留股份」一節「H. 發送領取股票

目的使用、持有及或保存(以任何方式):

電子退款指示退款支票」。

處理

閣下的申請及退款支票(如適用)

閣下提供給香港中央證券登記有限公司的資訊的

及核實是否符合本申請表格及招股章程

載列的條款和申請程序,以及公佈預留

有關影響

香港中央證券登記有限公司和其有關連的法人團

股份的分配結果;

遵守香港及其他地區的一切適用法律及

體、董事、高級人員、僱員及代理人(「代表」)在

法規;

法律所容許的最大限度內明確卸棄及免除在任何

登記新發行證券或以證券持有人的名義

方面與申請人或代表申請人在此文件提供的或與

(包括以香港結算代理人名義(如適用))

此文件或在此文件下提供的任何服務相關的任何

轉讓或受讓證券;

資料,或任何申請人或代表申請人提供與此文件

存置或更新本公司證券持有人的名冊;

或在此文件下提供的任何服務相關的任何其它書

核實或協助核實簽名、任何其他核證或

面或口頭通訊,有關或相關由申請人或任何其他

交換信息;

人士或實體所遭受或招致不論如何造成的任何損

確立本公司證券持有人的受益權利,如

失或損害的任何法律責任。此包括,但不限於,

股息、供股和紅股等;

該等資料中不論如何造成的任何錯誤或遺漏,或

分發本公司及其附屬公司的通訊;

Sample

代表或任何其他人士或實體對該等資料或任何該

編製統計信息和證券持有人資料;

等資料的文件記錄、影像、記錄或複製品作出的

根據香港或其他地區的法律、規則或規

任何依據,或其準確性、完整性、合時性或可靠

例進行披露(無論法定或其他規定);

性。

披露有關信息以便就權益提出申索;及

個人資料

與上述有關的任何其他附帶或相關目的

個人資料收集聲明

或使本公司及H 股證券登記處能履

香港法例第486 章《個人資料(私隱)條例》(「條

行對證券持有人及或監管機構承擔的

例」)的主要條款已於一九九六年十二月二十日在

責任及或證券持有人不時同意的任何

香港生效。此項個人資料收集聲明是向香港發售

其他目的。

3.

轉交個人資料

股份申請人和持有人說明有關本公司及其H 股證

本公司及H 股證券登記處持有關於證券申請

券登記處在個人資料和條例方面的政策和慣例。

人及持有人的個人資料將會保密,但本公司

1. 收集 閣下個人資料的原因

H 股證券登記處可以在達到上述目的或當

證券申請人或證券登記持有人以自己的名義

中任何目的的必要的情況下,作出彼等認為

申請認購證券或轉讓或受讓證券時或尋求H

必要的查詢以確認個人資料的準確性,尤其

股證券登記處的服務時,須不時向本公司及

彼等可向或從下列任何及全部人士和實體或

H 股證券登記處提供其最近的準確個人資

與下列任何及全部人士和實體互相披露、取

料。未能提供所要求的資料可能導致 閣下

得或轉移(無論在香港境內或境外)證券申請

申請證券被拒或延遲,或本公司或其H 股證

人及持有人的個人資料:

券登記處無法落實轉讓或提供服務,亦可能

本公司或彼等各自指定的代理,如財務

妨礙或延遲登記或轉讓 閣下成功申請認購

顧問和收款銀行;

的預留股份及或發送股票及或發送 閣

香港結算及香港結算代理人,彼等將會

下應得的退款支票。

就中央結算系統的運作使用個人資料(倘

如提供的個人資料有任何錯誤,證券持有人

申請人要求將預留股份記存於中央結算

須立即通知本公司和H 股證券登記處。

系統);

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

任何向本公司及H 股證券登記處提

外)。倘 閣下擬申請並非橙色申請表格申

供與其各自業務營運有關的行政、電

請保證配額表中載列的其中一個保證配額數

訊、電腦、付款或其他服務的代理、承

目, 閣下必須使用橙表eIPO 申請。倘 閣

包商或第三方服務供應商;

下擬申請保證配額以外的超額預留股份,則

聯交所、證監會及香港或其他地區的任

須填妥並簽署申請超額預留股份之橙色申請

何其他法定、監管或政府機關;及

表格,並單獨匯款足額支付所申請超額預留

證券持有人與其進行或擬進行交易的任

股份的應付股款,或透過www.eipo.com.hk

何其他人士或機構,如彼等的銀行、律

使用橙表eIPO 服務遞交申請。倘 閣下擬

師、會計師或股票經紀等。

申請相等於 閣下保證配額的預留股份數

4.

保留個人資料

目, 閣下應:(i) 填妥並簽署申請表格;及

本公司及H 股證券登記處將按收集個人資料

(ii) 提交一張支票(或銀行本票),金額須為申

所需的用途保留證券申請人及持有人的個人

請表格乙欄所印列確切金額。

資料。無需保留的個人資料將會根據條例銷

倘 閣下使用橙色申請表格申請超額預留

毀或處理。

股份, 閣下應:(i) 填寫所申請的超額預留

5.

查閱和更正個人資料

股份數目及應付金額(申請表格一覽表所載

條例規定,證券申請人及持有人有權確定

者);(ii) 填妥並簽署申請表格;及(iii) 提交

本公司或H 股證券登記處是否持有其個人資

一張獨立開出的支票(或銀行本票),金額須

料,並有權索取有關該資料的副本並更正任

為 閣下在申請表格填寫的相同金額。 閣

何不準確資料。根據條例,本公司和H 股證

下擬申請的超額預留股份數目必須為申請表

券登記處有權就處理任何查閱資料的要求收

格申請超額預留股份一覽表所載數目之一

取合理的費用。所有查閱資料或更正資料的

(香港結算代理人除外)。倘 閣下擬申請並

要求或查詢有關政策及慣例以及持有資料種

橙色申請表格申請超額預留股份表中載列

類的要求,均須按招股章程「公司資料」一節

的其中一個保證配額數目, 閣下必須使用

所披露或不時按適用法例獲知會的註冊地址

橙表eIPO 申請。

送交本公司公司秘書或送交H 股證券登記處

2.

請填妥並簽署申請表格。僅接納親筆簽名。

私隱監察人員。

3.

支票或銀行本票須緊釘於表格。 閣下必須

閣下簽署本申請表格,即表示 閣下同意上

以一張支票或一張銀行本票支付保證配額的

述各項。

申請款項及或以一張支票或一張銀行本票

申請程序

支付超額預留股份的申請款項。每份申請均

須附帶一張獨立支票或銀行本票。

除使用橙色申請表格外, 閣下亦可透過www.

如以支票繳付款項,該支票必須:

eipo.com.hk利用橙表eIPO 服務申請預留股份並

為港元支票;

使用繳費靈或網上銀行付款方法付款。

由香港的港元銀行賬戶開出;

1. 倘 閣下使用橙色申請表格申請保證配

顯示 閣下的賬戶名稱,而該賬戶名必

, 閣下可申請相等於或少於申請表格

須預印於支票,或由有關銀行授權人在

乙欄所列數目的保證配額的預留股份。

該支票背面簽署證明賬戶名。該賬戶名

倘 閣下擬申請少於 閣下保證配額的預

必須與 閣下於本表格上的姓名相同。

留股份, 閣下必須申請橙色申請表格申請

如屬聯名申請,則賬戶名稱必須與排名

Sample 首位申請人的名稱相同;

保證配額表中載列的其中一個保證配額數

目, 閣下應:(i) 填寫所申請的預留股份數

註明抬頭人為「中國銀行( 香港) 代理人

目及應付金額(申請表格一覽表所載者);

有限公司-復宏漢霖生物技術優先發

(ii) 填寫並簽署申請表格;及(iii) 提交一張

」;

支票(或銀行本票),金額須為 閣下在申

劃線註明「只准存入抬頭人賬戶」;及

請表格填寫的相同金額(香港結算代理人除

不得為期票。

橙表

閣下如為合資格復星國際股東且透過www.eipo.com.hk 進行網上申請時遇到困難,請使用本申請表格

下列情況將導致申請可能不獲受理:

九龍

旺角分行

彌敦道636 號招商永隆銀行中

支票不符合所有上述規定;或

心地庫

支票首次過戶時不獲兌現。

尖沙咀分行

加拿分道4

如以銀行本票繳付款項,該本票必須:

為港元;

新界

荃灣分行

沙咀道251

由香港持牌銀行發出,並由發出本票銀

行的授權人在本票背面簽署證明 閣下 5.

閣下可於下列時間遞交本申請表格:

姓名。本票背面所顯示姓名須與本申請

表格所填寫的姓名相同。如屬聯名申

二零一九年九月十二日(星期四)- 上午九時正至下午五時正

請,本票背面所示姓名必須與排名首位

二零一九年九月十三日(星期五)- 上午九時正至下午五時正

申請人的姓名相同;

二零一九年九月十六日(星期一)- 上午九時正至下午五時正

註明抬頭人為「中國銀行( 香港) 代理人

二零一九年九月十七日(星期二)- 上午九時正至中午十二時正

有限公司-復宏漢霖生物技術優先發 6.

遞交申請的截止時間是二零一九年九月十七

」;

日(星期二)中午十二時正,如該日並無開

劃線註明「只准存入抬頭人賬戶」;及

始登記認購申請,則為下一日開始登記認購

不得為期票。

申請的中午十二時正。本公司將於當日上午

如 閣下的支票或銀行本票不符合上述所有

規定,則

閣下的申請可能遭拒絕受理。

十一時四十五分至中午十二時正期間登記認

Sample

4. 將本申請表格對摺一次,然後投入中國銀行

購申請,惟須視乎當日天氣情況而定。如下

(香港)有限公司及招商永隆銀行有限公司的

列警告信號在二零一九年九月十七日(星期

下列任何一間分行的收集箱:

二)上午九時正至中午十二時正期間任何時

中國銀行(香港)有限公司

間在香港懸掛,將不會登記申請:

八號或以上颱風警告信號;

地區

分行名稱

地址

香港特別行政區政府公佈由超強颱風引

香港島

德輔道西分行

香港德輔道西111-119

起的極端環境;或

柴灣分行

香港柴灣道341-343 號宏德居

「黑色」暴雨警告信號。

B

如在該日的下一個營業日上午九時正至中午

十二時正期間任何時間並無懸掛上述任何警

九龍

德福廣場分行

九龍灣偉業街33 號德福廣場

告及或出現極端環境,申請認購登記將在

P2-P7號舖

該下一個營業日上午十一時四十五分至中午

奧海城分行

九龍海庭道18 號奧海城二期

十二時正期間開始。營業日指星期六、星期

日或香港公眾假期以外的日子。

一樓133

新界

7.

本公司保留將 閣下的一切或任何股款過戶

新都城分行

新界將軍澳新都城一期二樓

的權利,然而, 閣下的支票或銀行本票不

209

會於二零一九年九月十七日(星期二)中午

馬鞍山廣場分行

新界馬鞍山西沙路馬鞍山廣

十二時正前過戶。

閣下不會就已繳付款項

L2 2103

獲發收據。本公司將保留 閣下的申請款項

招商永隆銀行有限公司

的任何應得利息。在

閣下的支票或銀行本

票過戶前,本公司亦有權保留任何股票及

地區

分行名稱

地址

或任何多收的申請款項或退款。

香港島

總行

德輔道中45

堅尼地城分行

吉席街28

Disclaimer

HKEx - Hong Kong Exchanges and Clearing Ltd. published this content on 12 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2019 23:01:07 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HONG KONG EXCHANGES AND CL
12:51pHONG KONG EXCHANGES AND CLEARING : Italy approves law giving powers to protect M..
RE
08:08aDAVID SCHWIMMER : LSE CEO Schwimmer says feels 'very good' about Refinitiv deal
RE
08:06aLSE CEO Schwimmer says feels 'very good' about Refinitiv deal
RE
07:42aHONG KONG EXCHANGES AND CLEARING : Clarification announcement further informatio..
PU
09/18EXCLUSIVE : London Metal Exchange to delay ban on tainted metal until 2025 - sou..
RE
09/18HONG KONG EXCHANGES AND CLEARING : Poll result of the extraordinary general meet..
PU
09/18Britain to investigate £4 billion U.S. takeover of defence firm Cobham
RE
09/18HONG KONG EXCHANGES AND CLEARING : Resignation of independent non-executive dire..
PU
09/17HONG KONG EXCHANGES AND CLEARING : Green application form
PU
09/17HONG KONG EXCHANGES AND CLEARING : Yellow application form
PU
More news
Financials (HKD)
Sales 2019 16 340 M
EBIT 2019 11 538 M
Net income 2019 9 535 M
Finance 2019 51 058 M
Yield 2019 2,96%
P/E ratio 2019 30,4x
P/E ratio 2020 26,9x
EV / Sales2019 14,6x
EV / Sales2020 9,55x
Capitalization 289 B
Chart HONG KONG EXCHANGES AND CLEARING LIMITED
Duration : Period :
Hong Kong Exchanges and Clearing Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HONG KONG EXCHANGES AND CL
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 267,16  HKD
Last Close Price 230,20  HKD
Spread / Highest target 37,3%
Spread / Average Target 16,1%
Spread / Lowest Target -8,77%
EPS Revisions
Managers
NameTitle
Charles Xiaojia Li CEO & Ex-Officio Executive Director
May Lung Cha Chairman
Chi Kin Tai Joint Chief Operating Officer & Head-Clearing
Kwok Keung Lee Joint Chief Operating Officer
John F. Killian Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
HONG KONG EXCHANGES AND CLEARING LIMITED2.01%37 377
INTERCONTINENTAL EXCHANGE INC23.89%52 304
LONDON STOCK EXCHANGE78.63%31 591
DEUTSCHE BÖRSE AG32.68%28 238
B3 SA BRASIL BOLSA BALCAO0.00%22 443
NASDAQ25.81%16 900